| ENSG00000215039.2 |
VX-702 |
Breast invasive carcinoma |
0.01005422 |
Resistant |
| ENSG00000224596.3 |
VX-702 |
Breast invasive carcinoma |
0.012828875 |
Resistant |
| ENSG00000225822.3 |
VX-702 |
Breast invasive carcinoma |
0.025431782 |
Resistant |
| ENSG00000226690.2 |
VX-702 |
Breast invasive carcinoma |
0.012318947 |
Resistant |
| ENSG00000231081.1 |
VX-702 |
Breast invasive carcinoma |
0.019592211 |
Resistant |
| ENSG00000236546.1 |
VX-702 |
Breast invasive carcinoma |
0.02011832 |
Resistant |
| ENSG00000237637.1 |
VX-702 |
Breast invasive carcinoma |
0.032866628 |
Resistant |
| ENSG00000237773.1 |
VX-702 |
Breast invasive carcinoma |
0.044926313 |
Resistant |
| ENSG00000238123.1 |
VX-702 |
Breast invasive carcinoma |
0.012315281 |
Resistant |
| ENSG00000241732.1 |
VX-702 |
Breast invasive carcinoma |
0.047952857 |
Resistant |
| ENSG00000257176.1 |
VX-702 |
Breast invasive carcinoma |
0.033403307 |
Resistant |
| ENSG00000257568.1 |
VX-702 |
Breast invasive carcinoma |
0.036135654 |
Resistant |
| ENSG00000258455.1 |
VX-702 |
Breast invasive carcinoma |
0.049008099 |
Resistant |
| ENSG00000258952.1 |
VX-702 |
Breast invasive carcinoma |
0.027127965 |
Resistant |
| ENSG00000261582.1 |
VX-702 |
Breast invasive carcinoma |
0.014954033 |
Resistant |
| ENSG00000268266.1 |
VX-702 |
Breast invasive carcinoma |
0.028126939 |
Resistant |
| ENSG00000269895.1 |
VX-702 |
Breast invasive carcinoma |
0.039574164 |
Resistant |
| ENSG00000180139.10 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019124274 |
Resistant |
| ENSG00000203875.6 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047177503 |
Resistant |
| ENSG00000225213.2 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040158381 |
Resistant |
| ENSG00000225331.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017296803 |
Resistant |
| ENSG00000249492.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048018368 |
Resistant |
| ENSG00000254551.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029455057 |
Resistant |
| ENSG00000257824.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023583411 |
Resistant |
| ENSG00000259595.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048519402 |
Resistant |
| ENSG00000260515.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030446754 |
Resistant |
| ENSG00000260708.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006971687 |
Resistant |
| ENSG00000261780.2 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019733537 |
Resistant |
| ENSG00000261864.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028237448 |
Resistant |
| ENSG00000264729.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04377846 |
Resistant |
| ENSG00000271757.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026790262 |
Resistant |
| ENSG00000271998.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027520663 |
Resistant |
| ENSG00000273272.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043784464 |
Resistant |
| ENSG00000172250.10 |
VX-702 |
Esophageal cancer |
0.048822067 |
Resistant |
| ENSG00000203327.2 |
VX-702 |
Esophageal cancer |
0.028465934 |
Resistant |
| ENSG00000215386.6 |
VX-702 |
Esophageal cancer |
0.030115417 |
Resistant |
| ENSG00000225953.2 |
VX-702 |
Esophageal cancer |
0.035963823 |
Resistant |
| ENSG00000229955.1 |
VX-702 |
Esophageal cancer |
0.031485951 |
Resistant |
| ENSG00000232116.2 |
VX-702 |
Esophageal cancer |
0.021272176 |
Resistant |
| ENSG00000232164.1 |
VX-702 |
Esophageal cancer |
0.001006956 |
Resistant |
| ENSG00000232891.1 |
VX-702 |
Esophageal cancer |
0.025632037 |
Resistant |
| ENSG00000233013.4 |
VX-702 |
Esophageal cancer |
0.04487465 |
Resistant |
| ENSG00000235021.1 |
VX-702 |
Esophageal cancer |
0.020037713 |
Resistant |
| ENSG00000235072.1 |
VX-702 |
Esophageal cancer |
0.036115917 |
Resistant |
| ENSG00000236206.1 |
VX-702 |
Esophageal cancer |
0.040696874 |
Resistant |
| ENSG00000236383.3 |
VX-702 |
Esophageal cancer |
0.02609982 |
Resistant |
| ENSG00000236743.1 |
VX-702 |
Esophageal cancer |
0.024456715 |
Resistant |
| ENSG00000236780.1 |
VX-702 |
Esophageal cancer |
0.004976341 |
Resistant |
| ENSG00000240618.1 |
VX-702 |
Esophageal cancer |
0.04848133 |
Resistant |
| ENSG00000241860.2 |
VX-702 |
Esophageal cancer |
0.024568106 |
Resistant |
| ENSG00000241886.1 |
VX-702 |
Esophageal cancer |
0.019785207 |
Resistant |
| ENSG00000247317.3 |
VX-702 |
Esophageal cancer |
0.015682082 |
Resistant |
| ENSG00000248103.1 |
VX-702 |
Esophageal cancer |
0.001033902 |
Resistant |
| ENSG00000248740.1 |
VX-702 |
Esophageal cancer |
0.03274686 |
Resistant |
| ENSG00000249304.1 |
VX-702 |
Esophageal cancer |
0.011500631 |
Resistant |
| ENSG00000249593.2 |
VX-702 |
Esophageal cancer |
0.036182771 |
Resistant |
| ENSG00000250101.1 |
VX-702 |
Esophageal cancer |
0.008781195 |
Resistant |
| ENSG00000250155.1 |
VX-702 |
Esophageal cancer |
0.037573456 |
Resistant |
| ENSG00000250950.1 |
VX-702 |
Esophageal cancer |
0.0218661 |
Resistant |
| ENSG00000251003.3 |
VX-702 |
Esophageal cancer |
0.045114725 |
Resistant |
| ENSG00000255229.1 |
VX-702 |
Esophageal cancer |
0.008269827 |
Resistant |
| ENSG00000255318.1 |
VX-702 |
Esophageal cancer |
0.041711107 |
Resistant |
| ENSG00000257475.2 |
VX-702 |
Esophageal cancer |
0.036388627 |
Resistant |
| ENSG00000257534.1 |
VX-702 |
Esophageal cancer |
0.043027605 |
Resistant |
| ENSG00000259146.2 |
VX-702 |
Esophageal cancer |
0.043462611 |
Resistant |
| ENSG00000259542.1 |
VX-702 |
Esophageal cancer |
0.020668017 |
Resistant |
| ENSG00000260436.1 |
VX-702 |
Esophageal cancer |
0.041140273 |
Resistant |
| ENSG00000260932.1 |
VX-702 |
Esophageal cancer |
0.046440148 |
Resistant |
| ENSG00000263272.1 |
VX-702 |
Esophageal cancer |
0.023017828 |
Resistant |
| ENSG00000266934.1 |
VX-702 |
Esophageal cancer |
0.005587515 |
Resistant |
| ENSG00000267481.1 |
VX-702 |
Esophageal cancer |
0.008143684 |
Resistant |
| ENSG00000267729.1 |
VX-702 |
Esophageal cancer |
0.048120454 |
Resistant |
| ENSG00000268670.1 |
VX-702 |
Esophageal cancer |
0.015310375 |
Resistant |
| ENSG00000270190.1 |
VX-702 |
Esophageal cancer |
0.015247236 |
Resistant |
| ENSG00000271978.1 |
VX-702 |
Esophageal cancer |
0.006829053 |
Resistant |
| ENSG00000272221.1 |
VX-702 |
Esophageal cancer |
0.031551911 |
Resistant |
| ENSG00000272588.1 |
VX-702 |
Esophageal cancer |
0.015762934 |
Resistant |
| ENSG00000272904.1 |
VX-702 |
Esophageal cancer |
0.016843203 |
Resistant |
| ENSG00000273129.1 |
VX-702 |
Esophageal cancer |
0.021565369 |
Resistant |
| ENSG00000225210.5 |
VX-702 |
Head and neck squamous cell carcinoma |
0.041994307 |
Resistant |
| ENSG00000230439.2 |
VX-702 |
Head and neck squamous cell carcinoma |
0.030529504 |
Resistant |
| ENSG00000231666.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.033046929 |
Resistant |
| ENSG00000231826.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.016063417 |
Resistant |
| ENSG00000248143.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.010613175 |
Resistant |
| ENSG00000249731.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.00218425 |
Resistant |
| ENSG00000257642.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.029190091 |
Resistant |
| ENSG00000258137.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.02067306 |
Resistant |
| ENSG00000258168.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.014059345 |
Resistant |
| ENSG00000258325.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.032819591 |
Resistant |
| ENSG00000260196.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.036542655 |
Resistant |
| ENSG00000261786.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.006494025 |
Resistant |
| ENSG00000266278.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.032253688 |
Resistant |
| ENSG00000266579.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.038496764 |
Resistant |
| ENSG00000273267.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.027604351 |
Resistant |
| ENSG00000178977.3 |
VX-702 |
Kidney renal clear cell carcinoma |
0.001338868 |
Resistant |
| ENSG00000182310.8 |
VX-702 |
Kidney renal clear cell carcinoma |
0.003073999 |
Resistant |
| ENSG00000189196.4 |
VX-702 |
Kidney renal clear cell carcinoma |
0.044773284 |
Resistant |
| ENSG00000203356.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.030044219 |
Resistant |
| ENSG00000205054.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.000193292 |
Resistant |
| ENSG00000215808.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.016440247 |
Resistant |
| ENSG00000220161.4 |
VX-702 |
Kidney renal clear cell carcinoma |
0.022036859 |
Resistant |
| ENSG00000222041.6 |
VX-702 |
Kidney renal clear cell carcinoma |
0.005739526 |
Resistant |
| ENSG00000223749.3 |
VX-702 |
Kidney renal clear cell carcinoma |
0.012603804 |
Resistant |
| ENSG00000223969.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.0000372 |
Resistant |
| ENSG00000224577.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.020176037 |
Resistant |
| ENSG00000225111.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.04104098 |
Resistant |
| ENSG00000226047.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.035721734 |
Resistant |
| ENSG00000226472.3 |
VX-702 |
Kidney renal clear cell carcinoma |
0.030770521 |
Resistant |
| ENSG00000227060.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.017231853 |
Resistant |
| ENSG00000227963.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.038609379 |
Resistant |
| ENSG00000228775.3 |
VX-702 |
Kidney renal clear cell carcinoma |
0.017550901 |
Resistant |
| ENSG00000228793.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.043490248 |
Resistant |
| ENSG00000228956.4 |
VX-702 |
Kidney renal clear cell carcinoma |
0.001609972 |
Resistant |
| ENSG00000229382.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.0462288 |
Resistant |
| ENSG00000230825.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.003260717 |
Resistant |
| ENSG00000230836.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.000566826 |
Resistant |
| ENSG00000230990.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.000875529 |
Resistant |
| ENSG00000231154.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.009190437 |
Resistant |
| ENSG00000231563.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.035199009 |
Resistant |
| ENSG00000231663.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.000256948 |
Resistant |
| ENSG00000231806.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.044984009 |
Resistant |
| ENSG00000232065.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.028061812 |
Resistant |
| ENSG00000232969.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.023087101 |
Resistant |
| ENSG00000233223.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.007559634 |
Resistant |
| ENSG00000233532.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.045321862 |
Resistant |
| ENSG00000233621.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.023575226 |
Resistant |
| ENSG00000233791.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.025660772 |
Resistant |
| ENSG00000233818.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.003197614 |
Resistant |
| ENSG00000234323.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.018766427 |
Resistant |
| ENSG00000234327.3 |
VX-702 |
Kidney renal clear cell carcinoma |
0.012924294 |
Resistant |
| ENSG00000234698.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.046565839 |
Resistant |
| ENSG00000234869.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.03902637 |
Resistant |
| ENSG00000235398.4 |
VX-702 |
Kidney renal clear cell carcinoma |
0.046434867 |
Resistant |
| ENSG00000235831.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.02236185 |
Resistant |
| ENSG00000235949.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.007876647 |
Resistant |
| ENSG00000236404.4 |
VX-702 |
Kidney renal clear cell carcinoma |
0.026412619 |
Resistant |
| ENSG00000236618.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.015439053 |
Resistant |
| ENSG00000238280.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.030660073 |
Resistant |
| ENSG00000239213.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.028675817 |
Resistant |
| ENSG00000239774.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.016515157 |
Resistant |
| ENSG00000239911.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.038615013 |
Resistant |
| ENSG00000241954.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.049872264 |
Resistant |
| ENSG00000242759.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.013199856 |
Resistant |
| ENSG00000242808.3 |
VX-702 |
Kidney renal clear cell carcinoma |
0.027785767 |
Resistant |
| ENSG00000246731.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.021301175 |
Resistant |
| ENSG00000246863.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.021076356 |
Resistant |
| ENSG00000246877.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.019399834 |
Resistant |
| ENSG00000247675.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.021159329 |
Resistant |
| ENSG00000247796.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.020980348 |
Resistant |
| ENSG00000248079.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.00954063 |
Resistant |
| ENSG00000248323.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.012882448 |
Resistant |
| ENSG00000249084.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.023045547 |
Resistant |
| ENSG00000249159.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.016875732 |
Resistant |
| ENSG00000249413.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.012564549 |
Resistant |
| ENSG00000249609.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.037630507 |
Resistant |
| ENSG00000249740.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.011617937 |
Resistant |
| ENSG00000249859.3 |
VX-702 |
Kidney renal clear cell carcinoma |
0.01393339 |
Resistant |
| ENSG00000249911.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.001236337 |
Resistant |
| ENSG00000250303.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.002185911 |
Resistant |
| ENSG00000250988.3 |
VX-702 |
Kidney renal clear cell carcinoma |
0.04075294 |
Resistant |
| ENSG00000251143.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.039158428 |
Resistant |
| ENSG00000253327.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.00788122 |
Resistant |
| ENSG00000253671.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.000588454 |
Resistant |
| ENSG00000254057.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.005983154 |
Resistant |
| ENSG00000254258.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.000513326 |
Resistant |
| ENSG00000254554.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.037004064 |
Resistant |
| ENSG00000254689.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.003852306 |
Resistant |
| ENSG00000254879.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.041870612 |
Resistant |
| ENSG00000254910.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.02625354 |
Resistant |
| ENSG00000255345.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.000124145 |
Resistant |
| ENSG00000255367.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.020682297 |
Resistant |
| ENSG00000256092.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.040639762 |
Resistant |
| ENSG00000256124.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.00059942 |
Resistant |
| ENSG00000257167.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.014012749 |
Resistant |
| ENSG00000259561.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.019365687 |
Resistant |
| ENSG00000259672.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.00068401 |
Resistant |
| ENSG00000260160.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.030045773 |
Resistant |
| ENSG00000260285.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.04739519 |
Resistant |
| ENSG00000260366.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.004631736 |
Resistant |
| ENSG00000260409.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.017852054 |
Resistant |
| ENSG00000260493.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.017248071 |
Resistant |
| ENSG00000260924.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.01526227 |
Resistant |
| ENSG00000261253.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.042313596 |
Resistant |
| ENSG00000261431.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.022515027 |
Resistant |
| ENSG00000261534.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.002914144 |
Resistant |
| ENSG00000261840.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.049356894 |
Resistant |
| ENSG00000262117.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.043373343 |
Resistant |
| ENSG00000262136.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.042229839 |
Resistant |
| ENSG00000263063.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.021689945 |
Resistant |
| ENSG00000263327.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.007657404 |
Resistant |
| ENSG00000264448.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.022521673 |
Resistant |
| ENSG00000264672.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.006817667 |
Resistant |
| ENSG00000265542.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.028937136 |
Resistant |
| ENSG00000266289.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.021734876 |
Resistant |
| ENSG00000266927.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.005994743 |
Resistant |
| ENSG00000267151.2 |
VX-702 |
Kidney renal clear cell carcinoma |
0.01865972 |
Resistant |
| ENSG00000267321.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.045530442 |
Resistant |
| ENSG00000268520.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.025987971 |
Resistant |
| ENSG00000269246.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.017343548 |
Resistant |
| ENSG00000269986.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.011657652 |
Resistant |
| ENSG00000270332.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.01798662 |
Resistant |
| ENSG00000270673.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.023683509 |
Resistant |
| ENSG00000270972.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.010102154 |
Resistant |
| ENSG00000271762.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.025125492 |
Resistant |
| ENSG00000271874.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.004176092 |
Resistant |
| ENSG00000272128.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.028059301 |
Resistant |
| ENSG00000272709.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.000622164 |
Resistant |
| ENSG00000272764.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.039669382 |
Resistant |
| ENSG00000273297.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.042052843 |
Resistant |
| ENSG00000273473.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.008706029 |
Resistant |
| ENSG00000273486.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.023924639 |
Resistant |
| ENSG00000118412.8 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.022164215 |
Resistant |
| ENSG00000160336.10 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.025340651 |
Resistant |
| ENSG00000167912.5 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.030983968 |
Resistant |
| ENSG00000177369.4 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.047257295 |
Resistant |
| ENSG00000177757.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.010526503 |
Resistant |
| ENSG00000197332.7 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.016186394 |
Resistant |
| ENSG00000203288.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.021078327 |
Resistant |
| ENSG00000203321.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.001379741 |
Resistant |
| ENSG00000203327.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.026435811 |
Resistant |
| ENSG00000214955.5 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.032521345 |
Resistant |
| ENSG00000215159.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.028354183 |
Resistant |
| ENSG00000215424.5 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.004070302 |
Resistant |
| ENSG00000223356.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.029903317 |
Resistant |
| ENSG00000223525.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.04844387 |
Resistant |
| ENSG00000223695.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.002193835 |
Resistant |
| ENSG00000223813.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.01563999 |
Resistant |
| ENSG00000223839.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.022560545 |
Resistant |
| ENSG00000223882.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.001113162 |
Resistant |
| ENSG00000224043.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.008883405 |
Resistant |
| ENSG00000224078.8 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.035056371 |
Resistant |
| ENSG00000224093.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.036093079 |
Resistant |
| ENSG00000224358.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.035741866 |
Resistant |
| ENSG00000224490.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.009572764 |
Resistant |
| ENSG00000224635.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.033037925 |
Resistant |
| ENSG00000224905.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.013892142 |
Resistant |
| ENSG00000224985.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.034033856 |
Resistant |
| ENSG00000225075.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.004170401 |
Resistant |
| ENSG00000225393.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.000207768 |
Resistant |
| ENSG00000225762.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.045573365 |
Resistant |
| ENSG00000225798.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.040238621 |
Resistant |
| ENSG00000225891.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.011648488 |
Resistant |
| ENSG00000225948.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.008474576 |
Resistant |
| ENSG00000226266.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.012574107 |
Resistant |
| ENSG00000226496.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.040980716 |
Resistant |
| ENSG00000226548.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.02193098 |
Resistant |
| ENSG00000226669.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.010701859 |
Resistant |
| ENSG00000226851.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.019642628 |
Resistant |
| ENSG00000227155.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.011773076 |
Resistant |
| ENSG00000227245.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.039098371 |
Resistant |
| ENSG00000227409.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.008302861 |
Resistant |
| ENSG00000227527.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.033841114 |
Resistant |
| ENSG00000227673.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.037082794 |
Resistant |
| ENSG00000228274.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.045400073 |
Resistant |
| ENSG00000228288.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.017661928 |
Resistant |
| ENSG00000228544.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.0133101 |
Resistant |
| ENSG00000228614.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.016172561 |
Resistant |
| ENSG00000228677.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.048687482 |
Resistant |
| ENSG00000228794.4 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.019184993 |
Resistant |
| ENSG00000229021.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.047385901 |
Resistant |
| ENSG00000229348.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.002319558 |
Resistant |
| ENSG00000229484.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.033799367 |
Resistant |
| ENSG00000229582.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.016781874 |
Resistant |
| ENSG00000229739.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.015842666 |
Resistant |
| ENSG00000230013.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.017228255 |
Resistant |
| ENSG00000230021.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.02776922 |
Resistant |
| ENSG00000230424.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.002453743 |
Resistant |
| ENSG00000230736.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.035383241 |
Resistant |
| ENSG00000231512.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.010441913 |
Resistant |
| ENSG00000231563.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.009911137 |
Resistant |
| ENSG00000231769.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.017814594 |
Resistant |
| ENSG00000232063.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.011603013 |
Resistant |
| ENSG00000232104.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.010811378 |
Resistant |
| ENSG00000232110.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.02729505 |
Resistant |
| ENSG00000232545.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.001610357 |
Resistant |
| ENSG00000232593.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.022412866 |
Resistant |
| ENSG00000232648.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.001424536 |
Resistant |
| ENSG00000232712.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.030989913 |
Resistant |
| ENSG00000232892.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.039473468 |
Resistant |
| ENSG00000232907.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.047270796 |
Resistant |
| ENSG00000233178.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.001091772 |
Resistant |
| ENSG00000233244.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.037759175 |
Resistant |
| ENSG00000233251.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.020280067 |
Resistant |
| ENSG00000233723.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.045904868 |
Resistant |
| ENSG00000233757.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.030622055 |
Resistant |
| ENSG00000233775.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.031061311 |
Resistant |
| ENSG00000233806.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.021184804 |
Resistant |
| ENSG00000233885.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.002261654 |
Resistant |
| ENSG00000234019.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.009658773 |
Resistant |
| ENSG00000234134.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.03404946 |
Resistant |
| ENSG00000234915.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.000415277 |
Resistant |
| ENSG00000235257.4 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.007644951 |
Resistant |
| ENSG00000235262.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.027608669 |
Resistant |
| ENSG00000235326.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.008919526 |
Resistant |
| ENSG00000235423.4 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.029649342 |
Resistant |
| ENSG00000235545.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.026626419 |
Resistant |
| ENSG00000235609.4 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.024427594 |
Resistant |
| ENSG00000235880.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.043638777 |
Resistant |
| ENSG00000236051.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.033072112 |
Resistant |
| ENSG00000236432.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.032242121 |
Resistant |
| ENSG00000236472.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.010385831 |
Resistant |
| ENSG00000236545.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.006929118 |
Resistant |
| ENSG00000236703.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.001070396 |
Resistant |
| ENSG00000236772.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.020437847 |
Resistant |
| ENSG00000237073.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.024833442 |
Resistant |
| ENSG00000237359.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.047112644 |
Resistant |
| ENSG00000237852.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.039033897 |
Resistant |
| ENSG00000237940.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.044628544 |
Resistant |
| ENSG00000237945.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.020740416 |
Resistant |
| ENSG00000238123.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.002050286 |
Resistant |
| ENSG00000238141.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.024850631 |
Resistant |
| ENSG00000238197.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.008538199 |
Resistant |
| ENSG00000239828.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.006798838 |
Resistant |
| ENSG00000241679.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.016167734 |
Resistant |
| ENSG00000241954.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.040937314 |
Resistant |
| ENSG00000242628.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.039290915 |
Resistant |
| ENSG00000243230.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.044514761 |
Resistant |
| ENSG00000243433.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.023805148 |
Resistant |
| ENSG00000243701.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.004765491 |
Resistant |
| ENSG00000245598.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.034998457 |
Resistant |
| ENSG00000245928.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.007833173 |
Resistant |
| ENSG00000246225.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.008912374 |
Resistant |
| ENSG00000246323.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.00735149 |
Resistant |
| ENSG00000246448.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.032903793 |
Resistant |
| ENSG00000247151.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.014469849 |
Resistant |
| ENSG00000247679.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.010272282 |
Resistant |
| ENSG00000247775.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.037534823 |
Resistant |
| ENSG00000248399.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.030048293 |
Resistant |
| ENSG00000249602.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.023767123 |
Resistant |
| ENSG00000249631.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.032120757 |
Resistant |
| ENSG00000249684.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.012636373 |
Resistant |
| ENSG00000249786.3 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.038619524 |
Resistant |
| ENSG00000250012.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.029076262 |
Resistant |
| ENSG00000250129.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.043056637 |
Resistant |
| ENSG00000250132.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.005053829 |
Resistant |
| ENSG00000250938.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.029432262 |
Resistant |
| ENSG00000251152.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.024134619 |
Resistant |
| ENSG00000251600.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.014154807 |
Resistant |
| ENSG00000253133.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.028974765 |
Resistant |
| ENSG00000253444.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.030933205 |
Resistant |
| ENSG00000253476.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.040300783 |
Resistant |
| ENSG00000253875.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.045122779 |
Resistant |
| ENSG00000254039.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.025172942 |
Resistant |
| ENSG00000254340.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.042268814 |
Resistant |
| ENSG00000254869.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.010982322 |
Resistant |
| ENSG00000255142.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.024426882 |
Resistant |
| ENSG00000255145.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.048596757 |
Resistant |
| ENSG00000255160.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.033540509 |
Resistant |
| ENSG00000255240.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.030001051 |
Resistant |
| ENSG00000255241.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.045792819 |
Resistant |
| ENSG00000255308.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.045470976 |
Resistant |
| ENSG00000255893.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.00075727 |
Resistant |
| ENSG00000255966.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.004376859 |
Resistant |
| ENSG00000256020.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.024128855 |
Resistant |
| ENSG00000256742.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.022495138 |
Resistant |
| ENSG00000256789.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.006976259 |
Resistant |
| ENSG00000257038.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.04163628 |
Resistant |
| ENSG00000257647.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.049340759 |
Resistant |
| ENSG00000258101.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.001733543 |
Resistant |
| ENSG00000258137.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.041128107 |
Resistant |
| ENSG00000258334.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.028477399 |
Resistant |
| ENSG00000258545.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.045232014 |
Resistant |
| ENSG00000258704.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.0000323 |
Resistant |
| ENSG00000258711.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.019808625 |
Resistant |
| ENSG00000258821.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.04184382 |
Resistant |
| ENSG00000258831.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.048836822 |
Resistant |
| ENSG00000258851.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.038107621 |
Resistant |
| ENSG00000258935.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.029784288 |
Resistant |
| ENSG00000259353.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.038440809 |
Resistant |
| ENSG00000259418.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.01689698 |
Resistant |
| ENSG00000259463.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.019148376 |
Resistant |
| ENSG00000259488.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.032834739 |
Resistant |
| ENSG00000259709.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.045452891 |
Resistant |
| ENSG00000259760.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.03614283 |
Resistant |
| ENSG00000260167.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.01893911 |
Resistant |
| ENSG00000260252.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.011006764 |
Resistant |
| ENSG00000260269.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.000674023 |
Resistant |
| ENSG00000260329.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.035676889 |
Resistant |
| ENSG00000260351.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.030823689 |
Resistant |
| ENSG00000260394.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.00783682 |
Resistant |
| ENSG00000260447.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.031736681 |
Resistant |
| ENSG00000260626.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.014621296 |
Resistant |
| ENSG00000260672.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.007670518 |
Resistant |
| ENSG00000261069.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.020911432 |
Resistant |
| ENSG00000261096.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.015479794 |
Resistant |
| ENSG00000261135.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.019585147 |
Resistant |
| ENSG00000261200.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.044958886 |
Resistant |
| ENSG00000261266.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.017358289 |
Resistant |
| ENSG00000261737.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.015134566 |
Resistant |
| ENSG00000261823.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.03773523 |
Resistant |
| ENSG00000262678.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.042812334 |
Resistant |
| ENSG00000264078.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.014347021 |
Resistant |
| ENSG00000264107.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.025251255 |
Resistant |
| ENSG00000265334.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.034241635 |
Resistant |
| ENSG00000265443.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.037901287 |
Resistant |
| ENSG00000266313.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.010762357 |
Resistant |
| ENSG00000266456.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.04499923 |
Resistant |
| ENSG00000266644.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.035364991 |
Resistant |
| ENSG00000266911.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.029253609 |
Resistant |
| ENSG00000266999.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.04087918 |
Resistant |
| ENSG00000267198.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.016319095 |
Resistant |
| ENSG00000267212.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.005188371 |
Resistant |
| ENSG00000267246.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.008781979 |
Resistant |
| ENSG00000267345.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.045522233 |
Resistant |
| ENSG00000267348.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.016290323 |
Resistant |
| ENSG00000267388.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.015458178 |
Resistant |
| ENSG00000268364.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.030874418 |
Resistant |
| ENSG00000268392.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.027380298 |
Resistant |
| ENSG00000268970.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.027912079 |
Resistant |
| ENSG00000269489.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.04730027 |
Resistant |
| ENSG00000269656.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.015055219 |
Resistant |
| ENSG00000269696.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.048740257 |
Resistant |
| ENSG00000269938.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.038558884 |
Resistant |
| ENSG00000269997.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.042558275 |
Resistant |
| ENSG00000270028.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.026400694 |
Resistant |
| ENSG00000270110.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.03045931 |
Resistant |
| ENSG00000270174.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.037072422 |
Resistant |
| ENSG00000270704.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.016849876 |
Resistant |
| ENSG00000271218.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.014117713 |
Resistant |
| ENSG00000271347.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.01262337 |
Resistant |
| ENSG00000271576.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.02352187 |
Resistant |
| ENSG00000271734.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.02732854 |
Resistant |
| ENSG00000271738.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.042055836 |
Resistant |
| ENSG00000271743.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.032346911 |
Resistant |
| ENSG00000271757.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.005380395 |
Resistant |
| ENSG00000271978.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.004422881 |
Resistant |
| ENSG00000272070.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.022891011 |
Resistant |
| ENSG00000272217.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.018852161 |
Resistant |
| ENSG00000272462.2 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.010740583 |
Resistant |
| ENSG00000272558.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.005212027 |
Resistant |
| ENSG00000272562.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.00076705 |
Resistant |
| ENSG00000272657.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.045725261 |
Resistant |
| ENSG00000272668.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.040438387 |
Resistant |
| ENSG00000272795.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.049665437 |
Resistant |
| ENSG00000272810.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.03202732 |
Resistant |
| ENSG00000272870.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.019084529 |
Resistant |
| ENSG00000272885.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.037850181 |
Resistant |
| ENSG00000272905.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.01674249 |
Resistant |
| ENSG00000272933.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.017873332 |
Resistant |
| ENSG00000273033.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.027904066 |
Resistant |
| ENSG00000273381.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.015978005 |
Resistant |
| ENSG00000167912.5 |
VX-702 |
Brain lower grade glioma |
0.042332266 |
Resistant |
| ENSG00000177133.6 |
VX-702 |
Brain lower grade glioma |
0.033927899 |
Resistant |
| ENSG00000203801.4 |
VX-702 |
Brain lower grade glioma |
0.020125259 |
Resistant |
| ENSG00000223704.1 |
VX-702 |
Brain lower grade glioma |
0.003948706 |
Resistant |
| ENSG00000223930.1 |
VX-702 |
Brain lower grade glioma |
0.049792548 |
Resistant |
| ENSG00000224020.1 |
VX-702 |
Brain lower grade glioma |
0.036225513 |
Resistant |
| ENSG00000224875.2 |
VX-702 |
Brain lower grade glioma |
0.018160723 |
Resistant |
| ENSG00000224992.1 |
VX-702 |
Brain lower grade glioma |
0.006601006 |
Resistant |
| ENSG00000225138.3 |
VX-702 |
Brain lower grade glioma |
0.008686356 |
Resistant |
| ENSG00000225762.1 |
VX-702 |
Brain lower grade glioma |
0.006134457 |
Resistant |
| ENSG00000225964.1 |
VX-702 |
Brain lower grade glioma |
0.025599218 |
Resistant |
| ENSG00000226067.2 |
VX-702 |
Brain lower grade glioma |
0.020722156 |
Resistant |
| ENSG00000226472.3 |
VX-702 |
Brain lower grade glioma |
0.039941408 |
Resistant |
| ENSG00000226797.1 |
VX-702 |
Brain lower grade glioma |
0.037681057 |
Resistant |
| ENSG00000227481.1 |
VX-702 |
Brain lower grade glioma |
0.032721435 |
Resistant |
| ENSG00000228369.2 |
VX-702 |
Brain lower grade glioma |
0.029186893 |
Resistant |
| ENSG00000228857.2 |
VX-702 |
Brain lower grade glioma |
0.033032381 |
Resistant |
| ENSG00000229645.4 |
VX-702 |
Brain lower grade glioma |
0.037203744 |
Resistant |
| ENSG00000231217.1 |
VX-702 |
Brain lower grade glioma |
0.040926031 |
Resistant |
| ENSG00000231551.2 |
VX-702 |
Brain lower grade glioma |
0.031796825 |
Resistant |
| ENSG00000231709.1 |
VX-702 |
Brain lower grade glioma |
0.024803553 |
Resistant |
| ENSG00000233029.3 |
VX-702 |
Brain lower grade glioma |
0.049823865 |
Resistant |
| ENSG00000233860.1 |
VX-702 |
Brain lower grade glioma |
0.016393345 |
Resistant |
| ENSG00000233895.1 |
VX-702 |
Brain lower grade glioma |
0.018332338 |
Resistant |
| ENSG00000234428.2 |
VX-702 |
Brain lower grade glioma |
0.047677536 |
Resistant |
| ENSG00000234520.1 |
VX-702 |
Brain lower grade glioma |
0.034988719 |
Resistant |
| ENSG00000235033.3 |
VX-702 |
Brain lower grade glioma |
0.004163475 |
Resistant |
| ENSG00000235151.1 |
VX-702 |
Brain lower grade glioma |
0.017280829 |
Resistant |
| ENSG00000235664.1 |
VX-702 |
Brain lower grade glioma |
0.016609581 |
Resistant |
| ENSG00000235947.1 |
VX-702 |
Brain lower grade glioma |
0.042511948 |
Resistant |
| ENSG00000235999.1 |
VX-702 |
Brain lower grade glioma |
0.047498731 |
Resistant |
| ENSG00000237187.4 |
VX-702 |
Brain lower grade glioma |
0.009927336 |
Resistant |
| ENSG00000237234.2 |
VX-702 |
Brain lower grade glioma |
0.027607182 |
Resistant |
| ENSG00000237338.1 |
VX-702 |
Brain lower grade glioma |
0.022657341 |
Resistant |
| ENSG00000237738.1 |
VX-702 |
Brain lower grade glioma |
0.041695019 |
Resistant |
| ENSG00000244345.1 |
VX-702 |
Brain lower grade glioma |
0.044658026 |
Resistant |
| ENSG00000245694.4 |
VX-702 |
Brain lower grade glioma |
0.040683148 |
Resistant |
| ENSG00000246627.2 |
VX-702 |
Brain lower grade glioma |
0.002655303 |
Resistant |
| ENSG00000247157.2 |
VX-702 |
Brain lower grade glioma |
0.005842584 |
Resistant |
| ENSG00000248544.2 |
VX-702 |
Brain lower grade glioma |
0.04087288 |
Resistant |
| ENSG00000250192.1 |
VX-702 |
Brain lower grade glioma |
0.023118252 |
Resistant |
| ENSG00000250303.2 |
VX-702 |
Brain lower grade glioma |
0.027001279 |
Resistant |
| ENSG00000253355.1 |
VX-702 |
Brain lower grade glioma |
0.037982527 |
Resistant |
| ENSG00000253392.2 |
VX-702 |
Brain lower grade glioma |
0.008972389 |
Resistant |
| ENSG00000253641.1 |
VX-702 |
Brain lower grade glioma |
0.004208879 |
Resistant |
| ENSG00000253678.1 |
VX-702 |
Brain lower grade glioma |
0.034550371 |
Resistant |
| ENSG00000253829.1 |
VX-702 |
Brain lower grade glioma |
0.03677131 |
Resistant |
| ENSG00000254718.2 |
VX-702 |
Brain lower grade glioma |
0.021913809 |
Resistant |
| ENSG00000256237.1 |
VX-702 |
Brain lower grade glioma |
0.003600702 |
Resistant |
| ENSG00000256721.1 |
VX-702 |
Brain lower grade glioma |
0.022665882 |
Resistant |
| ENSG00000256982.1 |
VX-702 |
Brain lower grade glioma |
0.03136119 |
Resistant |
| ENSG00000257642.1 |
VX-702 |
Brain lower grade glioma |
0.031786754 |
Resistant |
| ENSG00000258096.1 |
VX-702 |
Brain lower grade glioma |
0.025848349 |
Resistant |
| ENSG00000258355.1 |
VX-702 |
Brain lower grade glioma |
0.012689081 |
Resistant |
| ENSG00000258733.1 |
VX-702 |
Brain lower grade glioma |
0.024456682 |
Resistant |
| ENSG00000259177.1 |
VX-702 |
Brain lower grade glioma |
0.037393449 |
Resistant |
| ENSG00000259319.1 |
VX-702 |
Brain lower grade glioma |
0.008203831 |
Resistant |
| ENSG00000259376.1 |
VX-702 |
Brain lower grade glioma |
0.046371529 |
Resistant |
| ENSG00000259863.1 |
VX-702 |
Brain lower grade glioma |
0.045050988 |
Resistant |
| ENSG00000259899.1 |
VX-702 |
Brain lower grade glioma |
0.044494917 |
Resistant |
| ENSG00000260579.1 |
VX-702 |
Brain lower grade glioma |
0.048076823 |
Resistant |
| ENSG00000260597.1 |
VX-702 |
Brain lower grade glioma |
0.038952397 |
Resistant |
| ENSG00000260601.1 |
VX-702 |
Brain lower grade glioma |
0.0195338 |
Resistant |
| ENSG00000260830.1 |
VX-702 |
Brain lower grade glioma |
0.02776131 |
Resistant |
| ENSG00000260977.1 |
VX-702 |
Brain lower grade glioma |
0.024439266 |
Resistant |
| ENSG00000260986.1 |
VX-702 |
Brain lower grade glioma |
0.024964891 |
Resistant |
| ENSG00000261451.1 |
VX-702 |
Brain lower grade glioma |
0.015488506 |
Resistant |
| ENSG00000261469.1 |
VX-702 |
Brain lower grade glioma |
0.037274546 |
Resistant |
| ENSG00000261574.1 |
VX-702 |
Brain lower grade glioma |
0.008277998 |
Resistant |
| ENSG00000261644.1 |
VX-702 |
Brain lower grade glioma |
0.043829056 |
Resistant |
| ENSG00000261827.1 |
VX-702 |
Brain lower grade glioma |
0.01247861 |
Resistant |
| ENSG00000262223.2 |
VX-702 |
Brain lower grade glioma |
0.049149699 |
Resistant |
| ENSG00000262903.1 |
VX-702 |
Brain lower grade glioma |
0.045453971 |
Resistant |
| ENSG00000264043.2 |
VX-702 |
Brain lower grade glioma |
0.045533407 |
Resistant |
| ENSG00000264630.1 |
VX-702 |
Brain lower grade glioma |
0.048788319 |
Resistant |
| ENSG00000264672.1 |
VX-702 |
Brain lower grade glioma |
0.038263636 |
Resistant |
| ENSG00000267201.1 |
VX-702 |
Brain lower grade glioma |
0.040815257 |
Resistant |
| ENSG00000267606.1 |
VX-702 |
Brain lower grade glioma |
0.012926917 |
Resistant |
| ENSG00000267776.1 |
VX-702 |
Brain lower grade glioma |
0.019371157 |
Resistant |
| ENSG00000267927.1 |
VX-702 |
Brain lower grade glioma |
0.044835289 |
Resistant |
| ENSG00000268751.1 |
VX-702 |
Brain lower grade glioma |
0.03896663 |
Resistant |
| ENSG00000269289.1 |
VX-702 |
Brain lower grade glioma |
0.038887374 |
Resistant |
| ENSG00000270022.2 |
VX-702 |
Brain lower grade glioma |
0.02656957 |
Resistant |
| ENSG00000271086.1 |
VX-702 |
Brain lower grade glioma |
0.017920978 |
Resistant |
| ENSG00000272181.1 |
VX-702 |
Brain lower grade glioma |
0.028726969 |
Resistant |
| ENSG00000272235.1 |
VX-702 |
Brain lower grade glioma |
0.015521042 |
Resistant |
| ENSG00000272236.1 |
VX-702 |
Brain lower grade glioma |
0.012462411 |
Resistant |
| ENSG00000272463.1 |
VX-702 |
Brain lower grade glioma |
0.047954343 |
Resistant |
| ENSG00000272483.1 |
VX-702 |
Brain lower grade glioma |
0.040581926 |
Resistant |
| ENSG00000272505.1 |
VX-702 |
Brain lower grade glioma |
0.020907659 |
Resistant |
| ENSG00000272609.1 |
VX-702 |
Brain lower grade glioma |
0.017790508 |
Resistant |
| ENSG00000272761.1 |
VX-702 |
Brain lower grade glioma |
0.03179539 |
Resistant |
| ENSG00000272789.1 |
VX-702 |
Brain lower grade glioma |
0.033827709 |
Resistant |
| ENSG00000273123.1 |
VX-702 |
Brain lower grade glioma |
0.048444836 |
Resistant |
| ENSG00000273257.1 |
VX-702 |
Brain lower grade glioma |
0.001467228 |
Resistant |
| ENSG00000273289.1 |
VX-702 |
Brain lower grade glioma |
0.009736633 |
Resistant |
| ENSG00000273368.1 |
VX-702 |
Brain lower grade glioma |
0.042787474 |
Resistant |
| ENSG00000146666.4 |
VX-702 |
Lung squamous cell carcinoma |
0.041501864 |
Resistant |
| ENSG00000187229.3 |
VX-702 |
Lung squamous cell carcinoma |
0.023302865 |
Resistant |
| ENSG00000203258.3 |
VX-702 |
Lung squamous cell carcinoma |
0.025532316 |
Resistant |
| ENSG00000203706.4 |
VX-702 |
Lung squamous cell carcinoma |
0.027686493 |
Resistant |
| ENSG00000204949.4 |
VX-702 |
Lung squamous cell carcinoma |
0.036147697 |
Resistant |
| ENSG00000206567.5 |
VX-702 |
Lung squamous cell carcinoma |
0.016123913 |
Resistant |
| ENSG00000223382.3 |
VX-702 |
Lung squamous cell carcinoma |
0.04125103 |
Resistant |
| ENSG00000223969.1 |
VX-702 |
Lung squamous cell carcinoma |
0.049596125 |
Resistant |
| ENSG00000224848.1 |
VX-702 |
Lung squamous cell carcinoma |
0.030530221 |
Resistant |
| ENSG00000225548.1 |
VX-702 |
Lung squamous cell carcinoma |
0.049017894 |
Resistant |
| ENSG00000225913.2 |
VX-702 |
Lung squamous cell carcinoma |
0.045142173 |
Resistant |
| ENSG00000225952.1 |
VX-702 |
Lung squamous cell carcinoma |
0.032479059 |
Resistant |
| ENSG00000226017.2 |
VX-702 |
Lung squamous cell carcinoma |
0.038753296 |
Resistant |
| ENSG00000227857.2 |
VX-702 |
Lung squamous cell carcinoma |
0.025055998 |
Resistant |
| ENSG00000228113.3 |
VX-702 |
Lung squamous cell carcinoma |
0.017298277 |
Resistant |
| ENSG00000228150.1 |
VX-702 |
Lung squamous cell carcinoma |
0.004691668 |
Resistant |
| ENSG00000229278.1 |
VX-702 |
Lung squamous cell carcinoma |
0.02810898 |
Resistant |
| ENSG00000229291.1 |
VX-702 |
Lung squamous cell carcinoma |
0.038596925 |
Resistant |
| ENSG00000229463.2 |
VX-702 |
Lung squamous cell carcinoma |
0.021256599 |
Resistant |
| ENSG00000230174.1 |
VX-702 |
Lung squamous cell carcinoma |
0.033984597 |
Resistant |
| ENSG00000230838.1 |
VX-702 |
Lung squamous cell carcinoma |
0.031030378 |
Resistant |
| ENSG00000231795.1 |
VX-702 |
Lung squamous cell carcinoma |
0.01363953 |
Resistant |
| ENSG00000232453.1 |
VX-702 |
Lung squamous cell carcinoma |
0.007405774 |
Resistant |
| ENSG00000232564.1 |
VX-702 |
Lung squamous cell carcinoma |
0.012573364 |
Resistant |
| ENSG00000232684.1 |
VX-702 |
Lung squamous cell carcinoma |
0.039120466 |
Resistant |
| ENSG00000232896.1 |
VX-702 |
Lung squamous cell carcinoma |
0.049418935 |
Resistant |
| ENSG00000233590.1 |
VX-702 |
Lung squamous cell carcinoma |
0.043292491 |
Resistant |
| ENSG00000233643.2 |
VX-702 |
Lung squamous cell carcinoma |
0.016114778 |
Resistant |
| ENSG00000233858.4 |
VX-702 |
Lung squamous cell carcinoma |
0.016626118 |
Resistant |
| ENSG00000234584.1 |
VX-702 |
Lung squamous cell carcinoma |
0.02680942 |
Resistant |
| ENSG00000235246.1 |
VX-702 |
Lung squamous cell carcinoma |
0.003195213 |
Resistant |
| ENSG00000235426.2 |
VX-702 |
Lung squamous cell carcinoma |
0.003351658 |
Resistant |
| ENSG00000235770.1 |
VX-702 |
Lung squamous cell carcinoma |
0.037729374 |
Resistant |
| ENSG00000237525.2 |
VX-702 |
Lung squamous cell carcinoma |
0.030924884 |
Resistant |
| ENSG00000237845.1 |
VX-702 |
Lung squamous cell carcinoma |
0.017548055 |
Resistant |
| ENSG00000237879.1 |
VX-702 |
Lung squamous cell carcinoma |
0.036637636 |
Resistant |
| ENSG00000239920.1 |
VX-702 |
Lung squamous cell carcinoma |
0.032833259 |
Resistant |
| ENSG00000240032.1 |
VX-702 |
Lung squamous cell carcinoma |
0.042241625 |
Resistant |
| ENSG00000241316.2 |
VX-702 |
Lung squamous cell carcinoma |
0.040382631 |
Resistant |
| ENSG00000241990.1 |
VX-702 |
Lung squamous cell carcinoma |
0.000180321 |
Resistant |
| ENSG00000249216.1 |
VX-702 |
Lung squamous cell carcinoma |
0.045068308 |
Resistant |
| ENSG00000249532.2 |
VX-702 |
Lung squamous cell carcinoma |
0.044377314 |
Resistant |
| ENSG00000249593.2 |
VX-702 |
Lung squamous cell carcinoma |
0.042907668 |
Resistant |
| ENSG00000250170.1 |
VX-702 |
Lung squamous cell carcinoma |
0.039747756 |
Resistant |
| ENSG00000250240.1 |
VX-702 |
Lung squamous cell carcinoma |
0.020540447 |
Resistant |
| ENSG00000250303.2 |
VX-702 |
Lung squamous cell carcinoma |
0.04957661 |
Resistant |
| ENSG00000250410.1 |
VX-702 |
Lung squamous cell carcinoma |
0.030804743 |
Resistant |
| ENSG00000250629.1 |
VX-702 |
Lung squamous cell carcinoma |
0.010557135 |
Resistant |
| ENSG00000255090.1 |
VX-702 |
Lung squamous cell carcinoma |
0.02974843 |
Resistant |
| ENSG00000255148.2 |
VX-702 |
Lung squamous cell carcinoma |
0.002230224 |
Resistant |
| ENSG00000256151.1 |
VX-702 |
Lung squamous cell carcinoma |
0.004892685 |
Resistant |
| ENSG00000256705.3 |
VX-702 |
Lung squamous cell carcinoma |
0.003797913 |
Resistant |
| ENSG00000257193.1 |
VX-702 |
Lung squamous cell carcinoma |
0.013623779 |
Resistant |
| ENSG00000257221.1 |
VX-702 |
Lung squamous cell carcinoma |
0.032843493 |
Resistant |
| ENSG00000257636.2 |
VX-702 |
Lung squamous cell carcinoma |
0.021838995 |
Resistant |
| ENSG00000258711.2 |
VX-702 |
Lung squamous cell carcinoma |
0.040904069 |
Resistant |
| ENSG00000259974.2 |
VX-702 |
Lung squamous cell carcinoma |
0.048659342 |
Resistant |
| ENSG00000260744.1 |
VX-702 |
Lung squamous cell carcinoma |
0.029934114 |
Resistant |
| ENSG00000261195.1 |
VX-702 |
Lung squamous cell carcinoma |
0.043986835 |
Resistant |
| ENSG00000262185.1 |
VX-702 |
Lung squamous cell carcinoma |
0.003894422 |
Resistant |
| ENSG00000266664.1 |
VX-702 |
Lung squamous cell carcinoma |
0.043696155 |
Resistant |
| ENSG00000267374.1 |
VX-702 |
Lung squamous cell carcinoma |
0.049331398 |
Resistant |
| ENSG00000267737.1 |
VX-702 |
Lung squamous cell carcinoma |
0.046061301 |
Resistant |
| ENSG00000267762.1 |
VX-702 |
Lung squamous cell carcinoma |
0.038022463 |
Resistant |
| ENSG00000267924.1 |
VX-702 |
Lung squamous cell carcinoma |
0.043689965 |
Resistant |
| ENSG00000269082.1 |
VX-702 |
Lung squamous cell carcinoma |
0.023003139 |
Resistant |
| ENSG00000269806.1 |
VX-702 |
Lung squamous cell carcinoma |
0.028354296 |
Resistant |
| ENSG00000269924.1 |
VX-702 |
Lung squamous cell carcinoma |
0.004328955 |
Resistant |
| ENSG00000271926.1 |
VX-702 |
Lung squamous cell carcinoma |
0.049056591 |
Resistant |
| ENSG00000272411.1 |
VX-702 |
Lung squamous cell carcinoma |
0.038297098 |
Resistant |
| ENSG00000273267.1 |
VX-702 |
Lung squamous cell carcinoma |
0.049095879 |
Resistant |
| ENSG00000152487.6 |
VX-702 |
Pancreatic adenocarcinoma |
0.018965281 |
Resistant |
| ENSG00000180846.4 |
VX-702 |
Pancreatic adenocarcinoma |
0.032346441 |
Resistant |
| ENSG00000181798.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.047766989 |
Resistant |
| ENSG00000185186.4 |
VX-702 |
Pancreatic adenocarcinoma |
0.028243179 |
Resistant |
| ENSG00000187229.3 |
VX-702 |
Pancreatic adenocarcinoma |
0.034775071 |
Resistant |
| ENSG00000188206.5 |
VX-702 |
Pancreatic adenocarcinoma |
0.036988292 |
Resistant |
| ENSG00000188825.9 |
VX-702 |
Pancreatic adenocarcinoma |
0.033671692 |
Resistant |
| ENSG00000189149.7 |
VX-702 |
Pancreatic adenocarcinoma |
0.043132163 |
Resistant |
| ENSG00000198106.7 |
VX-702 |
Pancreatic adenocarcinoma |
0.020613402 |
Resistant |
| ENSG00000204625.6 |
VX-702 |
Pancreatic adenocarcinoma |
0.001350027 |
Resistant |
| ENSG00000214837.4 |
VX-702 |
Pancreatic adenocarcinoma |
0.042142808 |
Resistant |
| ENSG00000215692.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.039829412 |
Resistant |
| ENSG00000215859.4 |
VX-702 |
Pancreatic adenocarcinoma |
0.038268931 |
Resistant |
| ENSG00000221817.5 |
VX-702 |
Pancreatic adenocarcinoma |
0.042570783 |
Resistant |
| ENSG00000223975.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.000774886 |
Resistant |
| ENSG00000224356.3 |
VX-702 |
Pancreatic adenocarcinoma |
0.025319097 |
Resistant |
| ENSG00000224533.3 |
VX-702 |
Pancreatic adenocarcinoma |
0.023025303 |
Resistant |
| ENSG00000225083.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.041600386 |
Resistant |
| ENSG00000225393.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.033838082 |
Resistant |
| ENSG00000225964.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.030763137 |
Resistant |
| ENSG00000226367.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.035494157 |
Resistant |
| ENSG00000226637.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.0127871 |
Resistant |
| ENSG00000227388.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.028933582 |
Resistant |
| ENSG00000227492.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.04407563 |
Resistant |
| ENSG00000227495.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.04417974 |
Resistant |
| ENSG00000227540.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.031444695 |
Resistant |
| ENSG00000227637.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.02757246 |
Resistant |
| ENSG00000228350.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.042704674 |
Resistant |
| ENSG00000228444.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.046016133 |
Resistant |
| ENSG00000229127.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.027343237 |
Resistant |
| ENSG00000229152.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.011822333 |
Resistant |
| ENSG00000229956.5 |
VX-702 |
Pancreatic adenocarcinoma |
0.039402278 |
Resistant |
| ENSG00000231028.4 |
VX-702 |
Pancreatic adenocarcinoma |
0.02064012 |
Resistant |
| ENSG00000231104.4 |
VX-702 |
Pancreatic adenocarcinoma |
0.022853382 |
Resistant |
| ENSG00000231731.3 |
VX-702 |
Pancreatic adenocarcinoma |
0.020162001 |
Resistant |
| ENSG00000231734.4 |
VX-702 |
Pancreatic adenocarcinoma |
0.002682098 |
Resistant |
| ENSG00000232063.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.015343486 |
Resistant |
| ENSG00000233396.3 |
VX-702 |
Pancreatic adenocarcinoma |
0.038129331 |
Resistant |
| ENSG00000233613.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.014098174 |
Resistant |
| ENSG00000234062.3 |
VX-702 |
Pancreatic adenocarcinoma |
0.048353938 |
Resistant |
| ENSG00000234197.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.036348269 |
Resistant |
| ENSG00000234509.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.004366779 |
Resistant |
| ENSG00000234869.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.043923609 |
Resistant |
| ENSG00000234899.5 |
VX-702 |
Pancreatic adenocarcinoma |
0.018450458 |
Resistant |
| ENSG00000235119.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.037711149 |
Resistant |
| ENSG00000235138.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.003306121 |
Resistant |
| ENSG00000235298.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.046047659 |
Resistant |
| ENSG00000235326.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.036824112 |
Resistant |
| ENSG00000235398.4 |
VX-702 |
Pancreatic adenocarcinoma |
0.01306212 |
Resistant |
| ENSG00000235437.3 |
VX-702 |
Pancreatic adenocarcinoma |
0.049185137 |
Resistant |
| ENSG00000235475.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.023574541 |
Resistant |
| ENSG00000235652.3 |
VX-702 |
Pancreatic adenocarcinoma |
0.048679067 |
Resistant |
| ENSG00000235999.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.0276991 |
Resistant |
| ENSG00000236364.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.018688438 |
Resistant |
| ENSG00000236810.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.02476524 |
Resistant |
| ENSG00000236896.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.002223669 |
Resistant |
| ENSG00000236943.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.012715365 |
Resistant |
| ENSG00000237476.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.00522384 |
Resistant |
| ENSG00000237489.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.030223021 |
Resistant |
| ENSG00000237505.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.008397017 |
Resistant |
| ENSG00000237689.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.029455642 |
Resistant |
| ENSG00000238058.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.031317605 |
Resistant |
| ENSG00000245149.3 |
VX-702 |
Pancreatic adenocarcinoma |
0.035544147 |
Resistant |
| ENSG00000245522.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.027814063 |
Resistant |
| ENSG00000246582.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.046992041 |
Resistant |
| ENSG00000247137.4 |
VX-702 |
Pancreatic adenocarcinoma |
0.047431328 |
Resistant |
| ENSG00000247373.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.047626269 |
Resistant |
| ENSG00000248668.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.043705575 |
Resistant |
| ENSG00000248671.3 |
VX-702 |
Pancreatic adenocarcinoma |
0.032970571 |
Resistant |
| ENSG00000248693.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.02618691 |
Resistant |
| ENSG00000249412.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.029662221 |
Resistant |
| ENSG00000250027.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.022571263 |
Resistant |
| ENSG00000250893.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.006706808 |
Resistant |
| ENSG00000250903.4 |
VX-702 |
Pancreatic adenocarcinoma |
0.007576453 |
Resistant |
| ENSG00000251131.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.015508339 |
Resistant |
| ENSG00000253854.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.024459836 |
Resistant |
| ENSG00000253878.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.046519649 |
Resistant |
| ENSG00000253948.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.044425575 |
Resistant |
| ENSG00000254604.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.025003638 |
Resistant |
| ENSG00000254860.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.009481966 |
Resistant |
| ENSG00000255234.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.028198779 |
Resistant |
| ENSG00000255495.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.037792048 |
Resistant |
| ENSG00000256751.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.030951673 |
Resistant |
| ENSG00000258428.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.009443941 |
Resistant |
| ENSG00000258515.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.038612554 |
Resistant |
| ENSG00000258904.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.046316522 |
Resistant |
| ENSG00000259310.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.021050795 |
Resistant |
| ENSG00000259417.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.019963925 |
Resistant |
| ENSG00000259577.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.031199844 |
Resistant |
| ENSG00000259628.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.03025538 |
Resistant |
| ENSG00000259673.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.016962735 |
Resistant |
| ENSG00000260425.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.045378801 |
Resistant |
| ENSG00000260436.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.032686212 |
Resistant |
| ENSG00000260526.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.014004599 |
Resistant |
| ENSG00000260528.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.039692043 |
Resistant |
| ENSG00000260853.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.047589812 |
Resistant |
| ENSG00000260855.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.024147809 |
Resistant |
| ENSG00000261131.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.00673134 |
Resistant |
| ENSG00000261141.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.00758342 |
Resistant |
| ENSG00000261634.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.019729456 |
Resistant |
| ENSG00000262380.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.026345333 |
Resistant |
| ENSG00000263220.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.047912646 |
Resistant |
| ENSG00000265218.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.025506626 |
Resistant |
| ENSG00000265800.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.037797353 |
Resistant |
| ENSG00000265943.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.009856561 |
Resistant |
| ENSG00000266850.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.022411521 |
Resistant |
| ENSG00000266918.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.024003828 |
Resistant |
| ENSG00000267002.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.03904208 |
Resistant |
| ENSG00000267197.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.010561135 |
Resistant |
| ENSG00000267474.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.017352592 |
Resistant |
| ENSG00000267838.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.02910997 |
Resistant |
| ENSG00000269652.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.031320272 |
Resistant |
| ENSG00000269815.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.030647431 |
Resistant |
| ENSG00000270157.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.00726486 |
Resistant |
| ENSG00000270720.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.00561026 |
Resistant |
| ENSG00000271172.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.011007303 |
Resistant |
| ENSG00000272425.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.049986817 |
Resistant |
| ENSG00000272635.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.035715618 |
Resistant |
| ENSG00000272904.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.029796193 |
Resistant |
| ENSG00000273011.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.025909014 |
Resistant |
| ENSG00000273367.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.044414787 |
Resistant |
| ENSG00000273369.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.021745186 |
Resistant |
| ENSG00000213468.3 |
VX-702 |
Sarcoma |
0.024493227 |
Resistant |
| ENSG00000223714.1 |
VX-702 |
Sarcoma |
0.013521637 |
Resistant |
| ENSG00000227070.1 |
VX-702 |
Sarcoma |
0.024863188 |
Resistant |
| ENSG00000227674.1 |
VX-702 |
Sarcoma |
0.028820485 |
Resistant |
| ENSG00000228988.1 |
VX-702 |
Sarcoma |
0.034479421 |
Resistant |
| ENSG00000230925.3 |
VX-702 |
Sarcoma |
0.002649363 |
Resistant |
| ENSG00000231595.1 |
VX-702 |
Sarcoma |
0.034357391 |
Resistant |
| ENSG00000232065.1 |
VX-702 |
Sarcoma |
0.025386458 |
Resistant |
| ENSG00000232093.1 |
VX-702 |
Sarcoma |
0.016383908 |
Resistant |
| ENSG00000232692.1 |
VX-702 |
Sarcoma |
0.029139971 |
Resistant |
| ENSG00000234160.1 |
VX-702 |
Sarcoma |
0.000219819 |
Resistant |
| ENSG00000234650.1 |
VX-702 |
Sarcoma |
0.037633494 |
Resistant |
| ENSG00000235530.2 |
VX-702 |
Sarcoma |
0.004729352 |
Resistant |
| ENSG00000235586.1 |
VX-702 |
Sarcoma |
0.0165258 |
Resistant |
| ENSG00000236472.1 |
VX-702 |
Sarcoma |
0.013790778 |
Resistant |
| ENSG00000236519.1 |
VX-702 |
Sarcoma |
0.003964378 |
Resistant |
| ENSG00000239593.1 |
VX-702 |
Sarcoma |
0.017620272 |
Resistant |
| ENSG00000239664.2 |
VX-702 |
Sarcoma |
0.013996751 |
Resistant |
| ENSG00000244184.1 |
VX-702 |
Sarcoma |
0.036571964 |
Resistant |
| ENSG00000248456.1 |
VX-702 |
Sarcoma |
0.04695046 |
Resistant |
| ENSG00000249502.1 |
VX-702 |
Sarcoma |
0.040361636 |
Resistant |
| ENSG00000254662.1 |
VX-702 |
Sarcoma |
0.035782214 |
Resistant |
| ENSG00000257596.1 |
VX-702 |
Sarcoma |
0.035179908 |
Resistant |
| ENSG00000259380.1 |
VX-702 |
Sarcoma |
0.007966339 |
Resistant |
| ENSG00000259762.1 |
VX-702 |
Sarcoma |
0.027147748 |
Resistant |
| ENSG00000260447.1 |
VX-702 |
Sarcoma |
0.004139164 |
Resistant |
| ENSG00000261442.1 |
VX-702 |
Sarcoma |
0.004829283 |
Resistant |
| ENSG00000261610.1 |
VX-702 |
Sarcoma |
0.031842822 |
Resistant |
| ENSG00000262580.1 |
VX-702 |
Sarcoma |
0.013288395 |
Resistant |
| ENSG00000264673.1 |
VX-702 |
Sarcoma |
0.035836558 |
Resistant |
| ENSG00000265739.1 |
VX-702 |
Sarcoma |
0.017645493 |
Resistant |
| ENSG00000265912.1 |
VX-702 |
Sarcoma |
0.043185616 |
Resistant |
| ENSG00000266445.1 |
VX-702 |
Sarcoma |
0.021471949 |
Resistant |
| ENSG00000267141.1 |
VX-702 |
Sarcoma |
0.034473264 |
Resistant |
| ENSG00000267449.1 |
VX-702 |
Sarcoma |
0.012306065 |
Resistant |
| ENSG00000268947.1 |
VX-702 |
Sarcoma |
0.031177747 |
Resistant |
| ENSG00000269161.1 |
VX-702 |
Sarcoma |
0.027776994 |
Resistant |
| ENSG00000269680.1 |
VX-702 |
Sarcoma |
0.013931898 |
Resistant |
| ENSG00000270068.1 |
VX-702 |
Sarcoma |
0.040970028 |
Resistant |
| ENSG00000272748.1 |
VX-702 |
Sarcoma |
0.040183259 |
Resistant |
| ENSG00000273061.1 |
VX-702 |
Sarcoma |
0.045631242 |
Resistant |
| ENSG00000136315.3 |
VX-702 |
Skin cutaneous melanoma |
0.005893186 |
Resistant |
| ENSG00000185433.4 |
VX-702 |
Skin cutaneous melanoma |
0.046923553 |
Resistant |
| ENSG00000205293.3 |
VX-702 |
Skin cutaneous melanoma |
0.048996395 |
Resistant |
| ENSG00000224511.1 |
VX-702 |
Skin cutaneous melanoma |
0.009813118 |
Resistant |
| ENSG00000224549.1 |
VX-702 |
Skin cutaneous melanoma |
0.007842712 |
Resistant |
| ENSG00000224933.2 |
VX-702 |
Skin cutaneous melanoma |
0.032538857 |
Resistant |
| ENSG00000225361.3 |
VX-702 |
Skin cutaneous melanoma |
0.036199354 |
Resistant |
| ENSG00000226281.2 |
VX-702 |
Skin cutaneous melanoma |
0.019713312 |
Resistant |
| ENSG00000226367.1 |
VX-702 |
Skin cutaneous melanoma |
0.001275098 |
Resistant |
| ENSG00000226856.1 |
VX-702 |
Skin cutaneous melanoma |
0.049085011 |
Resistant |
| ENSG00000227888.3 |
VX-702 |
Skin cutaneous melanoma |
0.038711949 |
Resistant |
| ENSG00000228386.2 |
VX-702 |
Skin cutaneous melanoma |
0.010896093 |
Resistant |
| ENSG00000229140.4 |
VX-702 |
Skin cutaneous melanoma |
0.020961047 |
Resistant |
| ENSG00000229891.1 |
VX-702 |
Skin cutaneous melanoma |
0.0018958 |
Resistant |
| ENSG00000230316.2 |
VX-702 |
Skin cutaneous melanoma |
0.009795622 |
Resistant |
| ENSG00000232290.1 |
VX-702 |
Skin cutaneous melanoma |
0.006778634 |
Resistant |
| ENSG00000235597.1 |
VX-702 |
Skin cutaneous melanoma |
0.026527619 |
Resistant |
| ENSG00000236194.2 |
VX-702 |
Skin cutaneous melanoma |
0.006765187 |
Resistant |
| ENSG00000237517.4 |
VX-702 |
Skin cutaneous melanoma |
0.019597074 |
Resistant |
| ENSG00000244998.1 |
VX-702 |
Skin cutaneous melanoma |
0.043087924 |
Resistant |
| ENSG00000246528.3 |
VX-702 |
Skin cutaneous melanoma |
0.004487765 |
Resistant |
| ENSG00000246851.1 |
VX-702 |
Skin cutaneous melanoma |
0.018875984 |
Resistant |
| ENSG00000250842.1 |
VX-702 |
Skin cutaneous melanoma |
0.015006082 |
Resistant |
| ENSG00000251445.1 |
VX-702 |
Skin cutaneous melanoma |
0.020785201 |
Resistant |
| ENSG00000253214.1 |
VX-702 |
Skin cutaneous melanoma |
0.001236019 |
Resistant |
| ENSG00000253878.1 |
VX-702 |
Skin cutaneous melanoma |
0.019527721 |
Resistant |
| ENSG00000254223.1 |
VX-702 |
Skin cutaneous melanoma |
0.007647121 |
Resistant |
| ENSG00000254343.2 |
VX-702 |
Skin cutaneous melanoma |
0.009195326 |
Resistant |
| ENSG00000254484.1 |
VX-702 |
Skin cutaneous melanoma |
0.044994299 |
Resistant |
| ENSG00000255084.1 |
VX-702 |
Skin cutaneous melanoma |
0.009488111 |
Resistant |
| ENSG00000257947.1 |
VX-702 |
Skin cutaneous melanoma |
0.018884113 |
Resistant |
| ENSG00000259687.1 |
VX-702 |
Skin cutaneous melanoma |
0.011942776 |
Resistant |
| ENSG00000261780.2 |
VX-702 |
Skin cutaneous melanoma |
0.023007817 |
Resistant |
| ENSG00000262202.3 |
VX-702 |
Skin cutaneous melanoma |
0.047519602 |
Resistant |
| ENSG00000262312.1 |
VX-702 |
Skin cutaneous melanoma |
0.007811636 |
Resistant |
| ENSG00000263154.1 |
VX-702 |
Skin cutaneous melanoma |
0.012149594 |
Resistant |
| ENSG00000263207.2 |
VX-702 |
Skin cutaneous melanoma |
0.047985993 |
Resistant |
| ENSG00000267638.1 |
VX-702 |
Skin cutaneous melanoma |
0.004261928 |
Resistant |
| ENSG00000269951.1 |
VX-702 |
Skin cutaneous melanoma |
0.012208852 |
Resistant |
| ENSG00000270640.1 |
VX-702 |
Skin cutaneous melanoma |
0.012959911 |
Resistant |
| ENSG00000272108.1 |
VX-702 |
Skin cutaneous melanoma |
0.037070738 |
Resistant |
| ENSG00000272518.1 |
VX-702 |
Skin cutaneous melanoma |
0.033704091 |
Resistant |
| ENSG00000273001.1 |
VX-702 |
Skin cutaneous melanoma |
0.03049383 |
Resistant |
| ENSG00000273381.1 |
VX-702 |
Skin cutaneous melanoma |
0.041615556 |
Resistant |
| ENSG00000203321.2 |
VX-702 |
Breast invasive carcinoma |
0.049572755 |
Sensitive |
| ENSG00000203441.2 |
VX-702 |
Breast invasive carcinoma |
0.00778145 |
Sensitive |
| ENSG00000214559.3 |
VX-702 |
Breast invasive carcinoma |
0.000243803 |
Sensitive |
| ENSG00000224107.1 |
VX-702 |
Breast invasive carcinoma |
0.032481016 |
Sensitive |
| ENSG00000224848.1 |
VX-702 |
Breast invasive carcinoma |
0.037754851 |
Sensitive |
| ENSG00000228013.1 |
VX-702 |
Breast invasive carcinoma |
0.001255973 |
Sensitive |
| ENSG00000228486.5 |
VX-702 |
Breast invasive carcinoma |
0.008779896 |
Sensitive |
| ENSG00000230131.1 |
VX-702 |
Breast invasive carcinoma |
0.010039515 |
Sensitive |
| ENSG00000230310.1 |
VX-702 |
Breast invasive carcinoma |
0.03196685 |
Sensitive |
| ENSG00000231024.1 |
VX-702 |
Breast invasive carcinoma |
0.045933422 |
Sensitive |
| ENSG00000232519.2 |
VX-702 |
Breast invasive carcinoma |
0.024789485 |
Sensitive |
| ENSG00000233360.4 |
VX-702 |
Breast invasive carcinoma |
0.038493726 |
Sensitive |
| ENSG00000233501.1 |
VX-702 |
Breast invasive carcinoma |
0.002955408 |
Sensitive |
| ENSG00000233937.2 |
VX-702 |
Breast invasive carcinoma |
0.001214348 |
Sensitive |
| ENSG00000235565.1 |
VX-702 |
Breast invasive carcinoma |
0.010145695 |
Sensitive |
| ENSG00000235760.3 |
VX-702 |
Breast invasive carcinoma |
0.01278485 |
Sensitive |
| ENSG00000236299.3 |
VX-702 |
Breast invasive carcinoma |
0.002273654 |
Sensitive |
| ENSG00000236498.1 |
VX-702 |
Breast invasive carcinoma |
0.008959997 |
Sensitive |
| ENSG00000236519.1 |
VX-702 |
Breast invasive carcinoma |
0.048512497 |
Sensitive |
| ENSG00000236545.1 |
VX-702 |
Breast invasive carcinoma |
0.000316028 |
Sensitive |
| ENSG00000236778.3 |
VX-702 |
Breast invasive carcinoma |
0.048862735 |
Sensitive |
| ENSG00000237718.1 |
VX-702 |
Breast invasive carcinoma |
0.039270624 |
Sensitive |
| ENSG00000237737.1 |
VX-702 |
Breast invasive carcinoma |
0.000893355 |
Sensitive |
| ENSG00000237927.1 |
VX-702 |
Breast invasive carcinoma |
0.000147486 |
Sensitive |
| ENSG00000238290.1 |
VX-702 |
Breast invasive carcinoma |
0.02949771 |
Sensitive |
| ENSG00000239930.2 |
VX-702 |
Breast invasive carcinoma |
0.025101316 |
Sensitive |
| ENSG00000244952.2 |
VX-702 |
Breast invasive carcinoma |
0.033237236 |
Sensitive |
| ENSG00000245060.2 |
VX-702 |
Breast invasive carcinoma |
0.019690547 |
Sensitive |
| ENSG00000246323.2 |
VX-702 |
Breast invasive carcinoma |
0.047633752 |
Sensitive |
| ENSG00000248468.1 |
VX-702 |
Breast invasive carcinoma |
0.04498245 |
Sensitive |
| ENSG00000250027.1 |
VX-702 |
Breast invasive carcinoma |
0.044587718 |
Sensitive |
| ENSG00000250057.1 |
VX-702 |
Breast invasive carcinoma |
0.01025791 |
Sensitive |
| ENSG00000250132.2 |
VX-702 |
Breast invasive carcinoma |
0.008730405 |
Sensitive |
| ENSG00000250312.2 |
VX-702 |
Breast invasive carcinoma |
0.016981887 |
Sensitive |
| ENSG00000250790.3 |
VX-702 |
Breast invasive carcinoma |
0.030724336 |
Sensitive |
| ENSG00000251022.2 |
VX-702 |
Breast invasive carcinoma |
0.014040151 |
Sensitive |
| ENSG00000253737.1 |
VX-702 |
Breast invasive carcinoma |
0.049150083 |
Sensitive |
| ENSG00000253741.1 |
VX-702 |
Breast invasive carcinoma |
0.001717676 |
Sensitive |
| ENSG00000253825.1 |
VX-702 |
Breast invasive carcinoma |
0.037360359 |
Sensitive |
| ENSG00000254267.1 |
VX-702 |
Breast invasive carcinoma |
0.04376244 |
Sensitive |
| ENSG00000254340.1 |
VX-702 |
Breast invasive carcinoma |
0.027489591 |
Sensitive |
| ENSG00000254433.1 |
VX-702 |
Breast invasive carcinoma |
0.047663796 |
Sensitive |
| ENSG00000254837.1 |
VX-702 |
Breast invasive carcinoma |
0.011338379 |
Sensitive |
| ENSG00000255089.1 |
VX-702 |
Breast invasive carcinoma |
0.04054834 |
Sensitive |
| ENSG00000256481.1 |
VX-702 |
Breast invasive carcinoma |
0.022063841 |
Sensitive |
| ENSG00000256588.1 |
VX-702 |
Breast invasive carcinoma |
0.001909228 |
Sensitive |
| ENSG00000256789.1 |
VX-702 |
Breast invasive carcinoma |
0.014400834 |
Sensitive |
| ENSG00000257999.1 |
VX-702 |
Breast invasive carcinoma |
0.004456431 |
Sensitive |
| ENSG00000258260.1 |
VX-702 |
Breast invasive carcinoma |
0.015683306 |
Sensitive |
| ENSG00000258520.1 |
VX-702 |
Breast invasive carcinoma |
0.046872573 |
Sensitive |
| ENSG00000259209.1 |
VX-702 |
Breast invasive carcinoma |
0.044840652 |
Sensitive |
| ENSG00000259254.1 |
VX-702 |
Breast invasive carcinoma |
0.00446429 |
Sensitive |
| ENSG00000259287.1 |
VX-702 |
Breast invasive carcinoma |
0.004532486 |
Sensitive |
| ENSG00000259319.1 |
VX-702 |
Breast invasive carcinoma |
0.00022654 |
Sensitive |
| ENSG00000259408.1 |
VX-702 |
Breast invasive carcinoma |
0.040042753 |
Sensitive |
| ENSG00000259515.1 |
VX-702 |
Breast invasive carcinoma |
0.031493087 |
Sensitive |
| ENSG00000259617.1 |
VX-702 |
Breast invasive carcinoma |
0.005915188 |
Sensitive |
| ENSG00000259768.3 |
VX-702 |
Breast invasive carcinoma |
0.002361494 |
Sensitive |
| ENSG00000260095.1 |
VX-702 |
Breast invasive carcinoma |
0.000993588 |
Sensitive |
| ENSG00000260136.1 |
VX-702 |
Breast invasive carcinoma |
0.005809089 |
Sensitive |
| ENSG00000260194.1 |
VX-702 |
Breast invasive carcinoma |
0.017335933 |
Sensitive |
| ENSG00000260774.1 |
VX-702 |
Breast invasive carcinoma |
0.029576917 |
Sensitive |
| ENSG00000261055.1 |
VX-702 |
Breast invasive carcinoma |
0.032181318 |
Sensitive |
| ENSG00000261302.1 |
VX-702 |
Breast invasive carcinoma |
0.0109042 |
Sensitive |
| ENSG00000261318.1 |
VX-702 |
Breast invasive carcinoma |
0.034079813 |
Sensitive |
| ENSG00000261481.1 |
VX-702 |
Breast invasive carcinoma |
0.022865517 |
Sensitive |
| ENSG00000261872.1 |
VX-702 |
Breast invasive carcinoma |
0.017538643 |
Sensitive |
| ENSG00000261924.1 |
VX-702 |
Breast invasive carcinoma |
0.036189554 |
Sensitive |
| ENSG00000264196.1 |
VX-702 |
Breast invasive carcinoma |
0.027014461 |
Sensitive |
| ENSG00000264207.1 |
VX-702 |
Breast invasive carcinoma |
0.00739665 |
Sensitive |
| ENSG00000264937.1 |
VX-702 |
Breast invasive carcinoma |
0.012708241 |
Sensitive |
| ENSG00000265912.1 |
VX-702 |
Breast invasive carcinoma |
0.001587089 |
Sensitive |
| ENSG00000266824.1 |
VX-702 |
Breast invasive carcinoma |
0.01513658 |
Sensitive |
| ENSG00000266900.1 |
VX-702 |
Breast invasive carcinoma |
0.010511527 |
Sensitive |
| ENSG00000267115.1 |
VX-702 |
Breast invasive carcinoma |
0.033902482 |
Sensitive |
| ENSG00000267198.1 |
VX-702 |
Breast invasive carcinoma |
0.015940109 |
Sensitive |
| ENSG00000267304.1 |
VX-702 |
Breast invasive carcinoma |
0.000422214 |
Sensitive |
| ENSG00000267347.1 |
VX-702 |
Breast invasive carcinoma |
0.048789802 |
Sensitive |
| ENSG00000267565.1 |
VX-702 |
Breast invasive carcinoma |
0.047263707 |
Sensitive |
| ENSG00000267666.1 |
VX-702 |
Breast invasive carcinoma |
0.037968251 |
Sensitive |
| ENSG00000267703.1 |
VX-702 |
Breast invasive carcinoma |
0.006390835 |
Sensitive |
| ENSG00000267786.1 |
VX-702 |
Breast invasive carcinoma |
0.019458666 |
Sensitive |
| ENSG00000267838.1 |
VX-702 |
Breast invasive carcinoma |
0.001279835 |
Sensitive |
| ENSG00000268670.1 |
VX-702 |
Breast invasive carcinoma |
0.034034622 |
Sensitive |
| ENSG00000268945.1 |
VX-702 |
Breast invasive carcinoma |
0.000117707 |
Sensitive |
| ENSG00000269161.1 |
VX-702 |
Breast invasive carcinoma |
0.014170048 |
Sensitive |
| ENSG00000269694.1 |
VX-702 |
Breast invasive carcinoma |
0.039743766 |
Sensitive |
| ENSG00000269814.1 |
VX-702 |
Breast invasive carcinoma |
0.005617473 |
Sensitive |
| ENSG00000269873.1 |
VX-702 |
Breast invasive carcinoma |
0.012341957 |
Sensitive |
| ENSG00000270332.1 |
VX-702 |
Breast invasive carcinoma |
0.032774782 |
Sensitive |
| ENSG00000270876.1 |
VX-702 |
Breast invasive carcinoma |
0.00047488 |
Sensitive |
| ENSG00000270996.1 |
VX-702 |
Breast invasive carcinoma |
0.033417479 |
Sensitive |
| ENSG00000271119.1 |
VX-702 |
Breast invasive carcinoma |
0.035327423 |
Sensitive |
| ENSG00000271888.1 |
VX-702 |
Breast invasive carcinoma |
0.021789739 |
Sensitive |
| ENSG00000272459.1 |
VX-702 |
Breast invasive carcinoma |
0.048820808 |
Sensitive |
| ENSG00000272462.2 |
VX-702 |
Breast invasive carcinoma |
0.023105836 |
Sensitive |
| ENSG00000272562.1 |
VX-702 |
Breast invasive carcinoma |
0.032053107 |
Sensitive |
| ENSG00000272682.1 |
VX-702 |
Breast invasive carcinoma |
0.009983775 |
Sensitive |
| ENSG00000272716.1 |
VX-702 |
Breast invasive carcinoma |
0.005304615 |
Sensitive |
| ENSG00000273113.1 |
VX-702 |
Breast invasive carcinoma |
0.00140454 |
Sensitive |
| ENSG00000273165.1 |
VX-702 |
Breast invasive carcinoma |
0.02099538 |
Sensitive |
| ENSG00000273374.1 |
VX-702 |
Breast invasive carcinoma |
0.038481165 |
Sensitive |
| ENSG00000273448.1 |
VX-702 |
Breast invasive carcinoma |
0.023876553 |
Sensitive |
| ENSG00000170590.4 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021426454 |
Sensitive |
| ENSG00000229807.5 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004358584 |
Sensitive |
| ENSG00000230735.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003390139 |
Sensitive |
| ENSG00000231305.3 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033823425 |
Sensitive |
| ENSG00000231724.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029136253 |
Sensitive |
| ENSG00000231865.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009147608 |
Sensitive |
| ENSG00000232274.2 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034825903 |
Sensitive |
| ENSG00000233154.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044052261 |
Sensitive |
| ENSG00000234494.3 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047385159 |
Sensitive |
| ENSG00000235481.2 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037127702 |
Sensitive |
| ENSG00000239002.2 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020019802 |
Sensitive |
| ENSG00000244345.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031397307 |
Sensitive |
| ENSG00000246740.2 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030341346 |
Sensitive |
| ENSG00000249753.2 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03485181 |
Sensitive |
| ENSG00000253616.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028421196 |
Sensitive |
| ENSG00000255234.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039285699 |
Sensitive |
| ENSG00000255670.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037242337 |
Sensitive |
| ENSG00000255843.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041364465 |
Sensitive |
| ENSG00000258942.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048560501 |
Sensitive |
| ENSG00000259364.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045163341 |
Sensitive |
| ENSG00000260608.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036839878 |
Sensitive |
| ENSG00000261723.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02395347 |
Sensitive |
| ENSG00000265908.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01760402 |
Sensitive |
| ENSG00000266993.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041437856 |
Sensitive |
| ENSG00000267750.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019968977 |
Sensitive |
| ENSG00000267798.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016547866 |
Sensitive |
| ENSG00000267858.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034025583 |
Sensitive |
| ENSG00000269951.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043831423 |
Sensitive |
| ENSG00000270091.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036791773 |
Sensitive |
| ENSG00000270117.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042145149 |
Sensitive |
| ENSG00000270641.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03061798 |
Sensitive |
| ENSG00000272576.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032111158 |
Sensitive |
| ENSG00000272709.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047801368 |
Sensitive |
| ENSG00000273381.1 |
VX-702 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020973465 |
Sensitive |
| ENSG00000204011.4 |
VX-702 |
Esophageal cancer |
0.049814778 |
Sensitive |
| ENSG00000229356.1 |
VX-702 |
Esophageal cancer |
0.03399084 |
Sensitive |
| ENSG00000230751.1 |
VX-702 |
Esophageal cancer |
0.049177039 |
Sensitive |
| ENSG00000236901.3 |
VX-702 |
Esophageal cancer |
0.020645831 |
Sensitive |
| ENSG00000237751.2 |
VX-702 |
Esophageal cancer |
0.033821791 |
Sensitive |
| ENSG00000238280.1 |
VX-702 |
Esophageal cancer |
0.002132457 |
Sensitive |
| ENSG00000250258.1 |
VX-702 |
Esophageal cancer |
0.03060109 |
Sensitive |
| ENSG00000253986.1 |
VX-702 |
Esophageal cancer |
0.010534851 |
Sensitive |
| ENSG00000254689.1 |
VX-702 |
Esophageal cancer |
0.020579019 |
Sensitive |
| ENSG00000259453.1 |
VX-702 |
Esophageal cancer |
0.000905969 |
Sensitive |
| ENSG00000266913.1 |
VX-702 |
Esophageal cancer |
0.031054889 |
Sensitive |
| ENSG00000270607.1 |
VX-702 |
Esophageal cancer |
0.043966758 |
Sensitive |
| ENSG00000272769.1 |
VX-702 |
Esophageal cancer |
0.043981917 |
Sensitive |
| ENSG00000223373.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.009139022 |
Sensitive |
| ENSG00000223774.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.049053698 |
Sensitive |
| ENSG00000224481.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.035113374 |
Sensitive |
| ENSG00000225889.3 |
VX-702 |
Head and neck squamous cell carcinoma |
0.03231008 |
Sensitive |
| ENSG00000226194.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.023235027 |
Sensitive |
| ENSG00000226465.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.015998295 |
Sensitive |
| ENSG00000227066.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.013914949 |
Sensitive |
| ENSG00000227161.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.044651755 |
Sensitive |
| ENSG00000227398.3 |
VX-702 |
Head and neck squamous cell carcinoma |
0.034731612 |
Sensitive |
| ENSG00000228010.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.019863538 |
Sensitive |
| ENSG00000228106.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.038579938 |
Sensitive |
| ENSG00000228526.2 |
VX-702 |
Head and neck squamous cell carcinoma |
0.020489386 |
Sensitive |
| ENSG00000228686.2 |
VX-702 |
Head and neck squamous cell carcinoma |
0.025444098 |
Sensitive |
| ENSG00000229195.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.04077651 |
Sensitive |
| ENSG00000229989.3 |
VX-702 |
Head and neck squamous cell carcinoma |
0.021800866 |
Sensitive |
| ENSG00000230300.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.025565203 |
Sensitive |
| ENSG00000230555.2 |
VX-702 |
Head and neck squamous cell carcinoma |
0.031438947 |
Sensitive |
| ENSG00000230753.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.008161554 |
Sensitive |
| ENSG00000230798.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.042060482 |
Sensitive |
| ENSG00000232536.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.025571222 |
Sensitive |
| ENSG00000233862.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.031496129 |
Sensitive |
| ENSG00000234350.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.02528002 |
Sensitive |
| ENSG00000234546.2 |
VX-702 |
Head and neck squamous cell carcinoma |
0.03530588 |
Sensitive |
| ENSG00000236404.4 |
VX-702 |
Head and neck squamous cell carcinoma |
0.046767291 |
Sensitive |
| ENSG00000237087.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.006637089 |
Sensitive |
| ENSG00000240449.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.018004112 |
Sensitive |
| ENSG00000241163.3 |
VX-702 |
Head and neck squamous cell carcinoma |
0.002383865 |
Sensitive |
| ENSG00000248027.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.033132235 |
Sensitive |
| ENSG00000248514.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.047215174 |
Sensitive |
| ENSG00000253302.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.031623916 |
Sensitive |
| ENSG00000253355.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.017595455 |
Sensitive |
| ENSG00000253552.3 |
VX-702 |
Head and neck squamous cell carcinoma |
0.048942669 |
Sensitive |
| ENSG00000254333.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.0038165 |
Sensitive |
| ENSG00000255774.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.004282824 |
Sensitive |
| ENSG00000257135.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.034823903 |
Sensitive |
| ENSG00000257261.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.031504256 |
Sensitive |
| ENSG00000257718.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.049956721 |
Sensitive |
| ENSG00000258558.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.048875698 |
Sensitive |
| ENSG00000258789.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.036874744 |
Sensitive |
| ENSG00000259448.2 |
VX-702 |
Head and neck squamous cell carcinoma |
0.04356283 |
Sensitive |
| ENSG00000259577.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.006166487 |
Sensitive |
| ENSG00000259645.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.040625813 |
Sensitive |
| ENSG00000259799.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.039652548 |
Sensitive |
| ENSG00000260671.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.028113519 |
Sensitive |
| ENSG00000263280.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.030290509 |
Sensitive |
| ENSG00000266283.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.012931609 |
Sensitive |
| ENSG00000271109.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.047703955 |
Sensitive |
| ENSG00000272369.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.005426648 |
Sensitive |
| ENSG00000273321.1 |
VX-702 |
Head and neck squamous cell carcinoma |
0.007861346 |
Sensitive |
| ENSG00000225806.3 |
VX-702 |
Kidney renal clear cell carcinoma |
0.043340295 |
Sensitive |
| ENSG00000225891.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.04457705 |
Sensitive |
| ENSG00000234084.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.030448493 |
Sensitive |
| ENSG00000234584.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.012957238 |
Sensitive |
| ENSG00000266922.1 |
VX-702 |
Kidney renal clear cell carcinoma |
0.035779058 |
Sensitive |
| ENSG00000167117.4 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.032088181 |
Sensitive |
| ENSG00000225643.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.037013051 |
Sensitive |
| ENSG00000237705.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.043595243 |
Sensitive |
| ENSG00000250786.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.024697452 |
Sensitive |
| ENSG00000254288.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.024809145 |
Sensitive |
| ENSG00000261369.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.032412134 |
Sensitive |
| ENSG00000266709.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.03991631 |
Sensitive |
| ENSG00000272829.1 |
VX-702 |
Chronic Lymphocytic Leukemia |
0.023533582 |
Sensitive |
| ENSG00000184324.11 |
VX-702 |
Brain lower grade glioma |
0.029970676 |
Sensitive |
| ENSG00000197463.8 |
VX-702 |
Brain lower grade glioma |
0.031381114 |
Sensitive |
| ENSG00000218018.2 |
VX-702 |
Brain lower grade glioma |
0.039288589 |
Sensitive |
| ENSG00000223660.1 |
VX-702 |
Brain lower grade glioma |
0.030986628 |
Sensitive |
| ENSG00000224635.1 |
VX-702 |
Brain lower grade glioma |
0.019733154 |
Sensitive |
| ENSG00000225532.1 |
VX-702 |
Brain lower grade glioma |
0.044179454 |
Sensitive |
| ENSG00000226276.1 |
VX-702 |
Brain lower grade glioma |
0.034332088 |
Sensitive |
| ENSG00000226334.1 |
VX-702 |
Brain lower grade glioma |
0.048874443 |
Sensitive |
| ENSG00000228614.1 |
VX-702 |
Brain lower grade glioma |
0.009443521 |
Sensitive |
| ENSG00000229137.2 |
VX-702 |
Brain lower grade glioma |
0.009005002 |
Sensitive |
| ENSG00000229901.1 |
VX-702 |
Brain lower grade glioma |
0.044542967 |
Sensitive |
| ENSG00000231486.3 |
VX-702 |
Brain lower grade glioma |
0.016390004 |
Sensitive |
| ENSG00000231992.1 |
VX-702 |
Brain lower grade glioma |
0.014066737 |
Sensitive |
| ENSG00000232458.1 |
VX-702 |
Brain lower grade glioma |
0.022144342 |
Sensitive |
| ENSG00000232827.2 |
VX-702 |
Brain lower grade glioma |
0.037405424 |
Sensitive |
| ENSG00000234945.3 |
VX-702 |
Brain lower grade glioma |
0.040788816 |
Sensitive |
| ENSG00000235077.1 |
VX-702 |
Brain lower grade glioma |
0.041386393 |
Sensitive |
| ENSG00000237438.2 |
VX-702 |
Brain lower grade glioma |
0.018507533 |
Sensitive |
| ENSG00000239219.2 |
VX-702 |
Brain lower grade glioma |
0.03428601 |
Sensitive |
| ENSG00000241772.2 |
VX-702 |
Brain lower grade glioma |
0.023987353 |
Sensitive |
| ENSG00000243433.1 |
VX-702 |
Brain lower grade glioma |
0.028845734 |
Sensitive |
| ENSG00000243885.1 |
VX-702 |
Brain lower grade glioma |
0.048104194 |
Sensitive |
| ENSG00000243926.1 |
VX-702 |
Brain lower grade glioma |
0.012155751 |
Sensitive |
| ENSG00000244310.1 |
VX-702 |
Brain lower grade glioma |
0.033210163 |
Sensitive |
| ENSG00000251298.1 |
VX-702 |
Brain lower grade glioma |
0.040924573 |
Sensitive |
| ENSG00000251604.1 |
VX-702 |
Brain lower grade glioma |
0.02907293 |
Sensitive |
| ENSG00000253567.1 |
VX-702 |
Brain lower grade glioma |
0.029692596 |
Sensitive |
| ENSG00000254224.1 |
VX-702 |
Brain lower grade glioma |
0.037155049 |
Sensitive |
| ENSG00000254231.1 |
VX-702 |
Brain lower grade glioma |
0.03782144 |
Sensitive |
| ENSG00000254401.1 |
VX-702 |
Brain lower grade glioma |
0.024374785 |
Sensitive |
| ENSG00000254615.2 |
VX-702 |
Brain lower grade glioma |
0.006657589 |
Sensitive |
| ENSG00000254699.1 |
VX-702 |
Brain lower grade glioma |
0.015066168 |
Sensitive |
| ENSG00000255050.1 |
VX-702 |
Brain lower grade glioma |
0.045219457 |
Sensitive |
| ENSG00000255362.1 |
VX-702 |
Brain lower grade glioma |
0.042740976 |
Sensitive |
| ENSG00000258815.1 |
VX-702 |
Brain lower grade glioma |
0.043927616 |
Sensitive |
| ENSG00000261775.1 |
VX-702 |
Brain lower grade glioma |
0.007123668 |
Sensitive |
| ENSG00000261838.1 |
VX-702 |
Brain lower grade glioma |
0.033737788 |
Sensitive |
| ENSG00000262823.1 |
VX-702 |
Brain lower grade glioma |
0.035240536 |
Sensitive |
| ENSG00000264270.1 |
VX-702 |
Brain lower grade glioma |
0.038647905 |
Sensitive |
| ENSG00000264853.1 |
VX-702 |
Brain lower grade glioma |
0.035913303 |
Sensitive |
| ENSG00000265334.1 |
VX-702 |
Brain lower grade glioma |
0.009147924 |
Sensitive |
| ENSG00000265845.2 |
VX-702 |
Brain lower grade glioma |
0.021205257 |
Sensitive |
| ENSG00000266313.1 |
VX-702 |
Brain lower grade glioma |
0.039055049 |
Sensitive |
| ENSG00000266402.2 |
VX-702 |
Brain lower grade glioma |
0.02344004 |
Sensitive |
| ENSG00000267347.1 |
VX-702 |
Brain lower grade glioma |
0.030097549 |
Sensitive |
| ENSG00000267449.1 |
VX-702 |
Brain lower grade glioma |
0.022606465 |
Sensitive |
| ENSG00000268186.1 |
VX-702 |
Brain lower grade glioma |
0.045160764 |
Sensitive |
| ENSG00000269148.1 |
VX-702 |
Brain lower grade glioma |
0.017454191 |
Sensitive |
| ENSG00000269321.1 |
VX-702 |
Brain lower grade glioma |
0.042799345 |
Sensitive |
| ENSG00000269983.1 |
VX-702 |
Brain lower grade glioma |
0.010938201 |
Sensitive |
| ENSG00000203496.4 |
VX-702 |
Lung squamous cell carcinoma |
0.014434093 |
Sensitive |
| ENSG00000215866.3 |
VX-702 |
Lung squamous cell carcinoma |
0.022286772 |
Sensitive |
| ENSG00000223821.1 |
VX-702 |
Lung squamous cell carcinoma |
0.027426672 |
Sensitive |
| ENSG00000224167.1 |
VX-702 |
Lung squamous cell carcinoma |
0.016117353 |
Sensitive |
| ENSG00000224592.1 |
VX-702 |
Lung squamous cell carcinoma |
0.01413353 |
Sensitive |
| ENSG00000226963.1 |
VX-702 |
Lung squamous cell carcinoma |
0.011067935 |
Sensitive |
| ENSG00000227838.1 |
VX-702 |
Lung squamous cell carcinoma |
0.047730017 |
Sensitive |
| ENSG00000230747.1 |
VX-702 |
Lung squamous cell carcinoma |
0.045130273 |
Sensitive |
| ENSG00000230914.2 |
VX-702 |
Lung squamous cell carcinoma |
0.030493955 |
Sensitive |
| ENSG00000231092.1 |
VX-702 |
Lung squamous cell carcinoma |
0.033054381 |
Sensitive |
| ENSG00000231881.1 |
VX-702 |
Lung squamous cell carcinoma |
0.041718895 |
Sensitive |
| ENSG00000234181.1 |
VX-702 |
Lung squamous cell carcinoma |
0.036763112 |
Sensitive |
| ENSG00000234418.1 |
VX-702 |
Lung squamous cell carcinoma |
0.037067263 |
Sensitive |
| ENSG00000234453.1 |
VX-702 |
Lung squamous cell carcinoma |
0.039435494 |
Sensitive |
| ENSG00000236065.2 |
VX-702 |
Lung squamous cell carcinoma |
0.030565374 |
Sensitive |
| ENSG00000236262.1 |
VX-702 |
Lung squamous cell carcinoma |
0.045236447 |
Sensitive |
| ENSG00000237336.1 |
VX-702 |
Lung squamous cell carcinoma |
0.046446746 |
Sensitive |
| ENSG00000237819.1 |
VX-702 |
Lung squamous cell carcinoma |
0.04520927 |
Sensitive |
| ENSG00000238062.1 |
VX-702 |
Lung squamous cell carcinoma |
0.021682459 |
Sensitive |
| ENSG00000239911.1 |
VX-702 |
Lung squamous cell carcinoma |
0.043608054 |
Sensitive |
| ENSG00000241054.1 |
VX-702 |
Lung squamous cell carcinoma |
0.036239684 |
Sensitive |
| ENSG00000244676.1 |
VX-702 |
Lung squamous cell carcinoma |
0.02429491 |
Sensitive |
| ENSG00000249293.1 |
VX-702 |
Lung squamous cell carcinoma |
0.037235134 |
Sensitive |
| ENSG00000249526.1 |
VX-702 |
Lung squamous cell carcinoma |
0.041585007 |
Sensitive |
| ENSG00000250986.1 |
VX-702 |
Lung squamous cell carcinoma |
0.046304143 |
Sensitive |
| ENSG00000253116.1 |
VX-702 |
Lung squamous cell carcinoma |
0.044365049 |
Sensitive |
| ENSG00000253430.1 |
VX-702 |
Lung squamous cell carcinoma |
0.013869039 |
Sensitive |
| ENSG00000253515.1 |
VX-702 |
Lung squamous cell carcinoma |
0.046937162 |
Sensitive |
| ENSG00000253535.1 |
VX-702 |
Lung squamous cell carcinoma |
0.025818891 |
Sensitive |
| ENSG00000253591.1 |
VX-702 |
Lung squamous cell carcinoma |
0.033492036 |
Sensitive |
| ENSG00000253618.1 |
VX-702 |
Lung squamous cell carcinoma |
0.036360899 |
Sensitive |
| ENSG00000253696.2 |
VX-702 |
Lung squamous cell carcinoma |
0.022436316 |
Sensitive |
| ENSG00000254468.1 |
VX-702 |
Lung squamous cell carcinoma |
0.02141304 |
Sensitive |
| ENSG00000254561.2 |
VX-702 |
Lung squamous cell carcinoma |
0.042781797 |
Sensitive |
| ENSG00000256325.1 |
VX-702 |
Lung squamous cell carcinoma |
0.005994356 |
Sensitive |
| ENSG00000257507.1 |
VX-702 |
Lung squamous cell carcinoma |
0.002378512 |
Sensitive |
| ENSG00000259031.1 |
VX-702 |
Lung squamous cell carcinoma |
0.048944504 |
Sensitive |
| ENSG00000259067.1 |
VX-702 |
Lung squamous cell carcinoma |
0.041688415 |
Sensitive |
| ENSG00000260650.1 |
VX-702 |
Lung squamous cell carcinoma |
0.045267795 |
Sensitive |
| ENSG00000261485.1 |
VX-702 |
Lung squamous cell carcinoma |
0.048899463 |
Sensitive |
| ENSG00000262482.1 |
VX-702 |
Lung squamous cell carcinoma |
0.016332138 |
Sensitive |
| ENSG00000262921.1 |
VX-702 |
Lung squamous cell carcinoma |
0.013375644 |
Sensitive |
| ENSG00000262951.1 |
VX-702 |
Lung squamous cell carcinoma |
0.032879991 |
Sensitive |
| ENSG00000266821.1 |
VX-702 |
Lung squamous cell carcinoma |
0.049143992 |
Sensitive |
| ENSG00000267437.1 |
VX-702 |
Lung squamous cell carcinoma |
0.041641048 |
Sensitive |
| ENSG00000267567.1 |
VX-702 |
Lung squamous cell carcinoma |
0.049891215 |
Sensitive |
| ENSG00000267940.1 |
VX-702 |
Lung squamous cell carcinoma |
0.048607875 |
Sensitive |
| ENSG00000268340.1 |
VX-702 |
Lung squamous cell carcinoma |
0.026543703 |
Sensitive |
| ENSG00000269177.1 |
VX-702 |
Lung squamous cell carcinoma |
0.044860134 |
Sensitive |
| ENSG00000269694.1 |
VX-702 |
Lung squamous cell carcinoma |
0.018731765 |
Sensitive |
| ENSG00000270020.1 |
VX-702 |
Lung squamous cell carcinoma |
0.049603817 |
Sensitive |
| ENSG00000270104.1 |
VX-702 |
Lung squamous cell carcinoma |
0.028239299 |
Sensitive |
| ENSG00000270522.1 |
VX-702 |
Lung squamous cell carcinoma |
0.045530813 |
Sensitive |
| ENSG00000272455.1 |
VX-702 |
Lung squamous cell carcinoma |
0.049674603 |
Sensitive |
| ENSG00000272966.1 |
VX-702 |
Lung squamous cell carcinoma |
0.037619879 |
Sensitive |
| ENSG00000273075.1 |
VX-702 |
Lung squamous cell carcinoma |
0.04544725 |
Sensitive |
| ENSG00000204044.5 |
VX-702 |
Pancreatic adenocarcinoma |
0.013153484 |
Sensitive |
| ENSG00000224871.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.02234743 |
Sensitive |
| ENSG00000226476.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.014481047 |
Sensitive |
| ENSG00000226716.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.023718873 |
Sensitive |
| ENSG00000227218.3 |
VX-702 |
Pancreatic adenocarcinoma |
0.030710138 |
Sensitive |
| ENSG00000228223.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.046318822 |
Sensitive |
| ENSG00000228423.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.016885155 |
Sensitive |
| ENSG00000229444.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.036812412 |
Sensitive |
| ENSG00000230894.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.035220867 |
Sensitive |
| ENSG00000230914.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.029642621 |
Sensitive |
| ENSG00000231920.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.030775895 |
Sensitive |
| ENSG00000232233.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.049489609 |
Sensitive |
| ENSG00000233785.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.0000308 |
Sensitive |
| ENSG00000235609.4 |
VX-702 |
Pancreatic adenocarcinoma |
0.001051426 |
Sensitive |
| ENSG00000244468.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.027741055 |
Sensitive |
| ENSG00000248787.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.036001191 |
Sensitive |
| ENSG00000253875.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.04321448 |
Sensitive |
| ENSG00000261685.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.002382925 |
Sensitive |
| ENSG00000261916.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.030069125 |
Sensitive |
| ENSG00000263098.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.04970741 |
Sensitive |
| ENSG00000266126.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.037805297 |
Sensitive |
| ENSG00000267734.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.007624957 |
Sensitive |
| ENSG00000267919.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.000393373 |
Sensitive |
| ENSG00000268568.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.041748204 |
Sensitive |
| ENSG00000270066.2 |
VX-702 |
Pancreatic adenocarcinoma |
0.020042891 |
Sensitive |
| ENSG00000272191.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.028398326 |
Sensitive |
| ENSG00000273069.1 |
VX-702 |
Pancreatic adenocarcinoma |
0.01456263 |
Sensitive |
| ENSG00000175873.3 |
VX-702 |
Sarcoma |
0.037409679 |
Sensitive |
| ENSG00000203588.3 |
VX-702 |
Sarcoma |
0.028737712 |
Sensitive |
| ENSG00000215304.3 |
VX-702 |
Sarcoma |
0.044438957 |
Sensitive |
| ENSG00000223732.2 |
VX-702 |
Sarcoma |
0.039431221 |
Sensitive |
| ENSG00000225806.3 |
VX-702 |
Sarcoma |
0.038408199 |
Sensitive |
| ENSG00000227486.1 |
VX-702 |
Sarcoma |
0.039523493 |
Sensitive |
| ENSG00000233006.2 |
VX-702 |
Sarcoma |
0.009585028 |
Sensitive |
| ENSG00000233930.3 |
VX-702 |
Sarcoma |
0.005185575 |
Sensitive |
| ENSG00000235437.3 |
VX-702 |
Sarcoma |
0.038666653 |
Sensitive |
| ENSG00000235802.1 |
VX-702 |
Sarcoma |
0.030084074 |
Sensitive |
| ENSG00000236830.2 |
VX-702 |
Sarcoma |
0.014544868 |
Sensitive |
| ENSG00000236871.2 |
VX-702 |
Sarcoma |
0.04222018 |
Sensitive |
| ENSG00000237188.3 |
VX-702 |
Sarcoma |
0.018777475 |
Sensitive |
| ENSG00000243069.3 |
VX-702 |
Sarcoma |
0.004476426 |
Sensitive |
| ENSG00000245729.1 |
VX-702 |
Sarcoma |
0.048457966 |
Sensitive |
| ENSG00000246859.2 |
VX-702 |
Sarcoma |
0.026509955 |
Sensitive |
| ENSG00000250629.1 |
VX-702 |
Sarcoma |
0.046554641 |
Sensitive |
| ENSG00000254607.2 |
VX-702 |
Sarcoma |
0.029186481 |
Sensitive |
| ENSG00000255310.2 |
VX-702 |
Sarcoma |
0.031384248 |
Sensitive |
| ENSG00000255495.1 |
VX-702 |
Sarcoma |
0.035812651 |
Sensitive |
| ENSG00000255970.1 |
VX-702 |
Sarcoma |
0.017324546 |
Sensitive |
| ENSG00000257027.1 |
VX-702 |
Sarcoma |
0.035708254 |
Sensitive |
| ENSG00000258302.1 |
VX-702 |
Sarcoma |
0.043159399 |
Sensitive |
| ENSG00000258663.1 |
VX-702 |
Sarcoma |
0.043381851 |
Sensitive |
| ENSG00000259319.1 |
VX-702 |
Sarcoma |
0.008666802 |
Sensitive |
| ENSG00000259782.2 |
VX-702 |
Sarcoma |
0.009989552 |
Sensitive |
| ENSG00000260693.1 |
VX-702 |
Sarcoma |
0.049514744 |
Sensitive |
| ENSG00000261064.1 |
VX-702 |
Sarcoma |
0.037657747 |
Sensitive |
| ENSG00000262372.1 |
VX-702 |
Sarcoma |
0.01318816 |
Sensitive |
| ENSG00000262837.1 |
VX-702 |
Sarcoma |
0.04337334 |
Sensitive |
| ENSG00000268015.1 |
VX-702 |
Sarcoma |
0.041564371 |
Sensitive |
| ENSG00000269834.1 |
VX-702 |
Sarcoma |
0.004503445 |
Sensitive |
| ENSG00000271948.1 |
VX-702 |
Sarcoma |
0.034510337 |
Sensitive |
| ENSG00000272468.1 |
VX-702 |
Sarcoma |
0.012096219 |
Sensitive |
| ENSG00000272650.1 |
VX-702 |
Sarcoma |
0.014785007 |
Sensitive |
| ENSG00000272799.1 |
VX-702 |
Sarcoma |
0.042011467 |
Sensitive |
| ENSG00000273071.1 |
VX-702 |
Sarcoma |
0.035939401 |
Sensitive |
| ENSG00000117242.7 |
VX-702 |
Skin cutaneous melanoma |
0.03734696 |
Sensitive |
| ENSG00000170919.11 |
VX-702 |
Skin cutaneous melanoma |
0.048638482 |
Sensitive |
| ENSG00000188660.3 |
VX-702 |
Skin cutaneous melanoma |
0.035088031 |
Sensitive |
| ENSG00000215068.3 |
VX-702 |
Skin cutaneous melanoma |
0.04642894 |
Sensitive |
| ENSG00000215447.3 |
VX-702 |
Skin cutaneous melanoma |
0.011054046 |
Sensitive |
| ENSG00000215483.4 |
VX-702 |
Skin cutaneous melanoma |
0.025120853 |
Sensitive |
| ENSG00000223382.3 |
VX-702 |
Skin cutaneous melanoma |
0.01690135 |
Sensitive |
| ENSG00000223749.3 |
VX-702 |
Skin cutaneous melanoma |
0.039358217 |
Sensitive |
| ENSG00000223768.1 |
VX-702 |
Skin cutaneous melanoma |
0.022887042 |
Sensitive |
| ENSG00000224093.1 |
VX-702 |
Skin cutaneous melanoma |
0.049734891 |
Sensitive |
| ENSG00000224638.1 |
VX-702 |
Skin cutaneous melanoma |
0.001046484 |
Sensitive |
| ENSG00000225886.1 |
VX-702 |
Skin cutaneous melanoma |
0.022700627 |
Sensitive |
| ENSG00000226194.1 |
VX-702 |
Skin cutaneous melanoma |
0.046245067 |
Sensitive |
| ENSG00000226754.1 |
VX-702 |
Skin cutaneous melanoma |
0.019485966 |
Sensitive |
| ENSG00000226852.2 |
VX-702 |
Skin cutaneous melanoma |
0.00921071 |
Sensitive |
| ENSG00000227006.1 |
VX-702 |
Skin cutaneous melanoma |
0.029608768 |
Sensitive |
| ENSG00000227456.3 |
VX-702 |
Skin cutaneous melanoma |
0.029155801 |
Sensitive |
| ENSG00000227487.3 |
VX-702 |
Skin cutaneous melanoma |
0.041112037 |
Sensitive |
| ENSG00000227681.1 |
VX-702 |
Skin cutaneous melanoma |
0.035662149 |
Sensitive |
| ENSG00000227811.2 |
VX-702 |
Skin cutaneous melanoma |
0.015256112 |
Sensitive |
| ENSG00000228237.1 |
VX-702 |
Skin cutaneous melanoma |
0.024555521 |
Sensitive |
| ENSG00000229111.1 |
VX-702 |
Skin cutaneous melanoma |
0.025126385 |
Sensitive |
| ENSG00000229388.1 |
VX-702 |
Skin cutaneous melanoma |
0.019322642 |
Sensitive |
| ENSG00000230058.1 |
VX-702 |
Skin cutaneous melanoma |
0.021779201 |
Sensitive |
| ENSG00000230812.1 |
VX-702 |
Skin cutaneous melanoma |
0.036551246 |
Sensitive |
| ENSG00000230898.1 |
VX-702 |
Skin cutaneous melanoma |
0.028910496 |
Sensitive |
| ENSG00000231346.1 |
VX-702 |
Skin cutaneous melanoma |
0.010657876 |
Sensitive |
| ENSG00000231563.1 |
VX-702 |
Skin cutaneous melanoma |
0.025911908 |
Sensitive |
| ENSG00000232453.1 |
VX-702 |
Skin cutaneous melanoma |
0.02801492 |
Sensitive |
| ENSG00000232811.1 |
VX-702 |
Skin cutaneous melanoma |
0.016037973 |
Sensitive |
| ENSG00000232913.3 |
VX-702 |
Skin cutaneous melanoma |
0.006171954 |
Sensitive |
| ENSG00000232977.2 |
VX-702 |
Skin cutaneous melanoma |
0.021880726 |
Sensitive |
| ENSG00000233077.1 |
VX-702 |
Skin cutaneous melanoma |
0.024798835 |
Sensitive |
| ENSG00000233427.1 |
VX-702 |
Skin cutaneous melanoma |
0.014789546 |
Sensitive |
| ENSG00000234336.2 |
VX-702 |
Skin cutaneous melanoma |
0.041237553 |
Sensitive |
| ENSG00000234535.1 |
VX-702 |
Skin cutaneous melanoma |
0.016556396 |
Sensitive |
| ENSG00000234754.1 |
VX-702 |
Skin cutaneous melanoma |
0.03140484 |
Sensitive |
| ENSG00000235314.1 |
VX-702 |
Skin cutaneous melanoma |
0.02184751 |
Sensitive |
| ENSG00000235837.1 |
VX-702 |
Skin cutaneous melanoma |
0.015915936 |
Sensitive |
| ENSG00000235902.1 |
VX-702 |
Skin cutaneous melanoma |
0.04910909 |
Sensitive |
| ENSG00000236021.1 |
VX-702 |
Skin cutaneous melanoma |
0.029789526 |
Sensitive |
| ENSG00000237126.4 |
VX-702 |
Skin cutaneous melanoma |
0.031858039 |
Sensitive |
| ENSG00000237505.2 |
VX-702 |
Skin cutaneous melanoma |
0.048943171 |
Sensitive |
| ENSG00000237753.1 |
VX-702 |
Skin cutaneous melanoma |
0.005014576 |
Sensitive |
| ENSG00000237798.1 |
VX-702 |
Skin cutaneous melanoma |
0.025581205 |
Sensitive |
| ENSG00000237819.1 |
VX-702 |
Skin cutaneous melanoma |
0.02276729 |
Sensitive |
| ENSG00000238005.2 |
VX-702 |
Skin cutaneous melanoma |
0.048254185 |
Sensitive |
| ENSG00000238160.1 |
VX-702 |
Skin cutaneous melanoma |
0.007140403 |
Sensitive |
| ENSG00000238197.1 |
VX-702 |
Skin cutaneous melanoma |
0.014901687 |
Sensitive |
| ENSG00000238279.1 |
VX-702 |
Skin cutaneous melanoma |
0.027415508 |
Sensitive |
| ENSG00000239920.1 |
VX-702 |
Skin cutaneous melanoma |
0.033997032 |
Sensitive |
| ENSG00000240093.1 |
VX-702 |
Skin cutaneous melanoma |
0.029624582 |
Sensitive |
| ENSG00000240687.1 |
VX-702 |
Skin cutaneous melanoma |
0.008301528 |
Sensitive |
| ENSG00000241520.1 |
VX-702 |
Skin cutaneous melanoma |
0.04738515 |
Sensitive |
| ENSG00000242808.3 |
VX-702 |
Skin cutaneous melanoma |
0.037844602 |
Sensitive |
| ENSG00000243069.3 |
VX-702 |
Skin cutaneous melanoma |
0.008429417 |
Sensitive |
| ENSG00000245975.2 |
VX-702 |
Skin cutaneous melanoma |
0.025156047 |
Sensitive |
| ENSG00000246308.1 |
VX-702 |
Skin cutaneous melanoma |
0.024144278 |
Sensitive |
| ENSG00000247809.3 |
VX-702 |
Skin cutaneous melanoma |
0.013466723 |
Sensitive |
| ENSG00000248079.2 |
VX-702 |
Skin cutaneous melanoma |
0.007954739 |
Sensitive |
| ENSG00000249216.1 |
VX-702 |
Skin cutaneous melanoma |
0.014654365 |
Sensitive |
| ENSG00000249249.1 |
VX-702 |
Skin cutaneous melanoma |
0.02978783 |
Sensitive |
| ENSG00000249345.2 |
VX-702 |
Skin cutaneous melanoma |
0.029023427 |
Sensitive |
| ENSG00000250156.3 |
VX-702 |
Skin cutaneous melanoma |
0.024818203 |
Sensitive |
| ENSG00000250602.1 |
VX-702 |
Skin cutaneous melanoma |
0.026328238 |
Sensitive |
| ENSG00000251602.2 |
VX-702 |
Skin cutaneous melanoma |
0.033550374 |
Sensitive |
| ENSG00000253837.1 |
VX-702 |
Skin cutaneous melanoma |
0.014248928 |
Sensitive |
| ENSG00000254180.1 |
VX-702 |
Skin cutaneous melanoma |
0.041218172 |
Sensitive |
| ENSG00000254391.1 |
VX-702 |
Skin cutaneous melanoma |
0.017756511 |
Sensitive |
| ENSG00000254416.1 |
VX-702 |
Skin cutaneous melanoma |
0.02446208 |
Sensitive |
| ENSG00000254539.1 |
VX-702 |
Skin cutaneous melanoma |
0.025059213 |
Sensitive |
| ENSG00000254859.1 |
VX-702 |
Skin cutaneous melanoma |
0.014469154 |
Sensitive |
| ENSG00000256448.1 |
VX-702 |
Skin cutaneous melanoma |
0.036823566 |
Sensitive |
| ENSG00000257354.1 |
VX-702 |
Skin cutaneous melanoma |
0.006866003 |
Sensitive |
| ENSG00000258701.1 |
VX-702 |
Skin cutaneous melanoma |
0.001731102 |
Sensitive |
| ENSG00000258851.1 |
VX-702 |
Skin cutaneous melanoma |
0.040411007 |
Sensitive |
| ENSG00000259245.1 |
VX-702 |
Skin cutaneous melanoma |
0.002506779 |
Sensitive |
| ENSG00000259523.1 |
VX-702 |
Skin cutaneous melanoma |
0.003738903 |
Sensitive |
| ENSG00000259676.1 |
VX-702 |
Skin cutaneous melanoma |
0.031208093 |
Sensitive |
| ENSG00000259763.1 |
VX-702 |
Skin cutaneous melanoma |
0.027082821 |
Sensitive |
| ENSG00000260635.1 |
VX-702 |
Skin cutaneous melanoma |
0.000584285 |
Sensitive |
| ENSG00000260910.1 |
VX-702 |
Skin cutaneous melanoma |
0.04707724 |
Sensitive |
| ENSG00000261654.1 |
VX-702 |
Skin cutaneous melanoma |
0.01769668 |
Sensitive |
| ENSG00000261712.1 |
VX-702 |
Skin cutaneous melanoma |
0.030149826 |
Sensitive |
| ENSG00000263680.2 |
VX-702 |
Skin cutaneous melanoma |
0.006108062 |
Sensitive |
| ENSG00000263843.1 |
VX-702 |
Skin cutaneous melanoma |
0.038087707 |
Sensitive |
| ENSG00000264932.2 |
VX-702 |
Skin cutaneous melanoma |
0.022143453 |
Sensitive |
| ENSG00000265091.1 |
VX-702 |
Skin cutaneous melanoma |
0.008683819 |
Sensitive |
| ENSG00000265445.1 |
VX-702 |
Skin cutaneous melanoma |
0.033941877 |
Sensitive |
| ENSG00000265519.1 |
VX-702 |
Skin cutaneous melanoma |
0.039329067 |
Sensitive |
| ENSG00000266654.1 |
VX-702 |
Skin cutaneous melanoma |
0.023960663 |
Sensitive |
| ENSG00000266941.1 |
VX-702 |
Skin cutaneous melanoma |
0.008773578 |
Sensitive |
| ENSG00000267161.1 |
VX-702 |
Skin cutaneous melanoma |
0.026508305 |
Sensitive |
| ENSG00000267192.1 |
VX-702 |
Skin cutaneous melanoma |
0.048134273 |
Sensitive |
| ENSG00000267493.2 |
VX-702 |
Skin cutaneous melanoma |
0.043218269 |
Sensitive |
| ENSG00000267649.1 |
VX-702 |
Skin cutaneous melanoma |
0.000982711 |
Sensitive |
| ENSG00000268095.1 |
VX-702 |
Skin cutaneous melanoma |
0.039901974 |
Sensitive |
| ENSG00000268584.1 |
VX-702 |
Skin cutaneous melanoma |
0.01386718 |
Sensitive |
| ENSG00000269019.1 |
VX-702 |
Skin cutaneous melanoma |
0.021147293 |
Sensitive |
| ENSG00000269976.1 |
VX-702 |
Skin cutaneous melanoma |
0.031234821 |
Sensitive |
| ENSG00000270177.1 |
VX-702 |
Skin cutaneous melanoma |
0.011977588 |
Sensitive |
| ENSG00000270346.1 |
VX-702 |
Skin cutaneous melanoma |
0.013782971 |
Sensitive |
| ENSG00000270462.1 |
VX-702 |
Skin cutaneous melanoma |
0.045906766 |
Sensitive |
| ENSG00000270604.1 |
VX-702 |
Skin cutaneous melanoma |
0.039183738 |
Sensitive |
| ENSG00000271327.1 |
VX-702 |
Skin cutaneous melanoma |
0.047540409 |
Sensitive |
| ENSG00000271367.1 |
VX-702 |
Skin cutaneous melanoma |
0.001478801 |
Sensitive |
| ENSG00000271590.1 |
VX-702 |
Skin cutaneous melanoma |
0.031087529 |
Sensitive |
| ENSG00000272142.1 |
VX-702 |
Skin cutaneous melanoma |
0.003926588 |
Sensitive |
| ENSG00000272158.1 |
VX-702 |
Skin cutaneous melanoma |
0.047898963 |
Sensitive |
| ENSG00000272562.1 |
VX-702 |
Skin cutaneous melanoma |
0.035537713 |
Sensitive |
| ENSG00000272696.1 |
VX-702 |
Skin cutaneous melanoma |
0.008263113 |
Sensitive |
| ENSG00000272745.1 |
VX-702 |
Skin cutaneous melanoma |
0.04822871 |
Sensitive |
| ENSG00000273108.1 |
VX-702 |
Skin cutaneous melanoma |
0.000295726 |
Sensitive |
| ENSG00000273148.1 |
VX-702 |
Skin cutaneous melanoma |
0.019282473 |
Sensitive |
| ENSG00000273186.1 |
VX-702 |
Skin cutaneous melanoma |
0.043144312 |
Sensitive |
| ENSG00000273230.1 |
VX-702 |
Skin cutaneous melanoma |
0.048357915 |
Sensitive |
| ENSG00000273232.1 |
VX-702 |
Skin cutaneous melanoma |
0.033629613 |
Sensitive |
| ENSG00000273454.1 |
VX-702 |
Skin cutaneous melanoma |
0.049635254 |
Sensitive |
